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1. Summary 
 
Infectious anaemia of pigs (IAP) is a disease caused by the haemotrophic bacterium 
Mycoplasma suis. The infection goes along with acute haemolytic anaemia, severe 
hypoglycaemia, bacteraemia and elevated body temperature. Antibiotic treatment by 
means of oxytetracycline saves animals from death but mycoplasmas are not 
eradicated. The disease goes over to the chronic state characterised by milder 
anaemia, acrocyanosis, higher susceptibility to other infections and growth 
retardation of piglets leading to economic consequences for affected farmers. 
Haemotrophic mycoplasmas are not cultivable in vitro. Therefore, infections with 
M. suis often are not recognised. These latently infected animals provide a reservoir 
and are of epidemiologic significance. M. suis is passed on to animals by 
transmission of infected blood mainly due to mechanical manipulations or by blood 
sucking arthropods.  
A main clinical sign of IAP is the autoimmune haemolytic anaemia. Due to drawbacks 
in research, i.e. the unculturability in vitro, not much is known about its pathogenesis. 
Clarification of mechanisms that lead to illness would support the establishment of 
treatment procedures and of a protective vaccination. Earlier studies revealed the 
presence of cold reactive antibodies targeting red blood cells. These mainly occur 
during the chronic phase and are responsible for the cyanosis observed at the acra. 
Agglutination of the red blood cells in the periphery leads to cell lysis and decreased 
haematocrit levels. In addition, autoreactive antibodies of the isotype IgG are 
upregulated during phases with acute clinical signs. In this thesis, actin was identified 
as target protein of these warm reactive antibodies.  
The normal life span of a red blood cell is about 120 days. To prevent haemolysis 
and inflammation senescent red blood cells are safely removed from the circulation 
system by means of programmed cell death (eryptosis). Breakdown of membrane 
asymmetry represents a signal for macrophages to ingest the affected cell and to 
transport it to the spleen or liver for sequestration. Programmed cell death is as well 
induced upon stress. An example is malaria. Cells infected with Plasmodium 
falciparum are recognised and eliminated by macrophages. Here, eryptosis 
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represents a defence mechanism against intracellular pathogens. In this thesis, the 
occurrence of eryptosis in M. suis infected pigs was described and evaluated for 
impact on anaemia development. The pattern of eryptosis occurrence depends on 
the M. suis strain. In infections with strains of low virulence, eryptosis is observed at 
the beginning of infection and seems to protect the animal from severe anaemia by 
removal of infected cells from the circulation system. In fact, in pigs infected with a 
highly virulent strain eryptosis and severity of anaemia correlate. Due to high 
numbers of cleared cells severe anaemia occurs. Later on, intravascular lysis due to 
another mechanism was observed.  
The anaemia is most distinct at time points of maximal bacteraemia indicating that 
the direct interaction of M. suis with its host cell is important for development of 
anaemia. Attachment is a prerequisite for M. suis to invade the red blood cell. By 
doing so, significant deformations and destructions are induced leading to cell lysis. A 
promising approach to ease the clinical sign of anaemia would be to prevent this 
attachment process. For this, knowledge of attachment proteins is indispensable. 
MSG1, a protein homologous to glyceraldehyde-3-phosphate dehydrogenase was 
shown earlier to be involved in the attachment process. The protein was used to 
vaccinate pigs prior to experimental infection with M. suis. However, no protection 
was achieved.  
In vitro studies performed in connection with this doctoral thesis indicated that actin 
was the interaction partner of MSG1 on the red blood cell. Interaction with actin 
would lead to rearrangement and conformational changes of the protein which could 
induce the aforementioned misled immune response directed against host actin.  
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2. Zusammenfassung 
 
Die infektiöse Anämie des Schweins (IAP) wird durch Mycoplasma suis verursacht. 
Symptome sind akute immun-hämolytische Anämie, starke Hypoglykämie, 
Bakteriämie und hohes Fieber. Eine Behandlung mit Oxytetrazyklin verhindert, dass 
die Schweine sterben, vermag aber nicht, den Erreger komplett aus dem Organismus 
zu eliminieren. Die Krankheit geht in ein chronisches Stadium über, das durch 
leichtere Anämie, Zyanosen an den Akren, ein erhöhtes Risiko für andere 
Infektionskrankheiten und Wachstumsverzögerungen der Ferkel gekennzeichnet ist. 
Die Symptome während der chronischen Phase sind hauptsächlich für die 
wirtschaftlichen Schäden verantwortlich. M. suis gehört zu der Gruppe der haemo-
trophen Mykoplasmen, die im Labor nicht kultivierbar sind. Daher werden sie in der 
Routinediagnostik oft nicht erkannt. Gesunde Tiere werden mit M. suis infiziertem 
Blut angesteckt was vor allem iatrogen oder durch blutsaugende Insekten erfolgen 
kann. 
Ein Hauptsymptom der IAP ist die autoimmunhämolytische Anämie, über deren 
Pathogenese fast nichts bekannt ist. Der Grund dafür liegt an der Unkultivierbarkeit 
von M. suis, was die Forschung deutlich erschwert. Eine Aufklärung der 
Pathogenitätsmechanismen wäre sehr hilfreich für die Verbesserung von 
Therapiemöglichkeiten und die Entwicklung eines Impfstoffs. In früheren Studien 
wurde gezeigt, dass während der chronischen Phase Kälteagglutinine gebildet 
werden. Hierbei handelt es sich um autoreaktive Antikörper, die bei erniedrigter 
Körpertemperatur an die Erythrozyten binden und diese so agglutinieren. Dies führt 
zu einer Behinderung des Blutflusses in den Kapillaren und daher zu Zyanosen an 
den Extremitäten, insbesondere an den Ohrrändern. Eine Bindung der 
Kälteagglutinine an die Erythrozyten führt zu Agglutination und Zelllyse gefolgt von 
einer Erniedrigung des Hämatokrits. Zusätzlich zu den Kälteagglutininen werden 
während der akuten Krankheitsstadien autoreaktive IgG Antikörper gebildet. In dieser 
Dissertation wurde Aktin als Autoantigen für die IgG Antikörper identifiziert.  
Die normale Lebensdauer eines Erythrozyten beträgt ungefähr 120 Tage. Nach 
dieser Zeit wird die Zelle durch den Mechanismus des programmierten Zelltods aus 
dem Blutkreislauf entfernt ohne Entzündungsreaktionen oder Hämolyse auszulösen. 
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Dieser Prozess wird in Analogie zur Apoptose anderer Zellen Eryptose genannt. 
Durch äussere Signale wird die Membranasymmetrie aufgehoben, was zur 
Aufnahme durch Makrophagen führt. Diese transportieren die Zelle zur Milz oder 
Leber, wo sie dann abgebaut wird. Bei Malaria dient die Eryptose als 
Verteidigungsmechanismus, da Zellen, die mit Plasmodien infiziert sind, gezielt 
abgebaut werden. In der vorliegenden Doktorarbeit wurde das Auftreten der Eryptose 
in mit M. suis infizierten Schweinen untersucht und in den Zusammenhang mit der 
Anämiepathogenese gestellt. Bei Tieren, die mit einem wenig virulenten M. suis 
Stamm infiziert wurden, konnten Eryptoseprozesse zu Beginn der Infektion erkannt 
werden. Die Tiere zeigten keine Anämie und überlebten ohne Behandlung, was 
darauf hindeutet, dass M. suis infizierte Blutzellen sofort aus dem Blutkreislauf 
entfernt wurden bevor Symptome entstehen konnten. Bei Schweinen, die mit einem 
virulenteren M. suis Stamm infiziert waren, konnte eine Hochregulierung der 
Eryptose-Aktivität beobachtet werden, die mit dem Schweregrad der Anämie 
korrelierte. Da sehr viele Zellen mit M. suis infiziert sind und daher mittels Eryptose 
aus dem Blutkreislauf entfernt werden, entsteht Anämie. Später im Infektionsverlauf 
wurde zusätzlich eine intravaskuläre Lyse der roten Blutzellen beobachtet.  
Die infektiöse Anämie beim Schwein ist besonders stark ausgeprägt wenn der 
Erregerbefall sehr hoch ist. Dies ist ein Hinweis darauf, dass M. suis einen direkten 
Einfluss auf die Hämolyse und damit die Anämie hat. Hämolyse kann durch starke 
Schäden und Deformationen an der Plasmamembran der Wirtszelle ausgelöst 
werden, die entstehen wenn M. suis an die Zelle adhäriert.  Die Symptome der IAP 
könnten also durch Hemmung des Adhäsionsvorganges gelindert werden. Bisher ist 
erst ein Adhäsionsprotein von M. suis detailliert beschrieben. Hierbei handelt es sich 
um MSG1, ein Protein, das der Glyceraldehyde-3-phosphat dehydrogenase sehr 
ähnlich ist. Das Protein wurde als potentielle Vakzine getestet, konnte aber keine 
Protektion vermitteln. In vitro Experimente, die im Zusammenhang mit der 
vorliegenden Doktorarbeit durchgeführt wurden, zeigten, dass Aktin der roten 
Blutzellen ein Bindungspartner von MSG1 ist. Eine Bindung induziert Umlagerungen 
und strukturelle Veränderungen am Aktin, was zu der oben erwähnten fehlgeleiteten 
Immunantwort führen könnte. 
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3. Introduction 
 
3.1 The genus Mycoplasma  
3.1.1 Microbial properties 
Mycoplasmas are bacteria lacking a cell wall. They are the smallest organisms (0.2 to 
2 µm in diameter) known to be able to live autonomously. Mycoplasmas are 
pleomorphic and naturally resistant to antibiotics targeting cell wall synthesis. The 
genome sizes vary between 0.5 and 2.0 x 109 Da (0.5 to 2.0 kb) [1]. A characteristic 
for Mycoplasma is a low GC content of the DNA (23-46 mol %) [2]. Further, they use 
an alternate genetic code i.e. the Mycoplasma / Spiroplasma code (No. 4) that 
translates UGA, a common stop codon, into the amino acid tryptophan. Due to the 
reduced genome and the requirement for sterol for cell membrane rigidity most 
species are closely dependent on a host cell and are therefore difficult to cultivate in 
vitro. 
 3.1.2 Taxonomy 
Bacteria lacking a cell wall are classified within the phylum Tenericutes (lat. tener – 
tender; cutis - skin) which comprises one class, the Mollicutes (lat. mollis – soft) [3]. 
The Mollicutes are further divided into five orders, one of which is referred to as the 
Mycoplasmatales. The single family within this order is called Mycoplasmataceae and 
harbours two genera, Mycoplasma and Ureaplasma. Based on the 16S rDNA 
sequences the genus Mycoplasma is assigned into three non taxonomical groups, 
i.e. pneumoniae, hominis and fermentans. The pneumoniae group divides into 
several clusters, one of which consists of haemotrophic mycoplasmas (HM), also 
called haemoplasmas [4].  
3.1.3 Pathogenicity 
Depending on the species, mycoplasmas exhibit commensalic, parasitic or 
saprophytic lifestyles. Pathogenic species isolated from vertebrates often cause 
inflammations in the respiratory tract (M. pneumoniae, M. mycoides subsp. mycoides, 
M. gallisepticum), in the genitourinary tract (M. hominis, M. genitalium) and in joints 
(M. arthritidis) [5-7]. Additionally, they can cause sepsis (e.g. M. mycoides subsp. 
mycoides, M. pneumoniae, M. hominis) [8-10]. 
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Most pathogenic mycoplasmas express attachment proteins. M. pneumoniae for 
example developed a tip structure used for adherence and gliding motility on 
surfaces. Other mechanisms are toxins and mitogenic components (M. neurolyticum, 
M. arthritidis) [11, 12].  
The bacteria often have to survive in inhospitable environments namely on cells 
exposed to a flow of body fluids. Therefore they developed mechanisms to induce 
morphologic and metabolic alterations in host cells to establish a suitable niche to 
avoid detection by the host’s immune system. The interference with immune 
response often lead to development of clinical symptoms as inflammation and misled 
immune responses [13]. The ability of mycoplasmas to influence the immune system 
to their advantage allows for persistency and therefore favours development of 
chronic diseases. Thus, mycoplasmas attract more and more notice to medical 
research. As an example, M. pneumoniae was recently detected to be involved in the 
pathogenesis of adult rheumatoid arthritis, juvenile idiopathic arthritis, Crohn’s 
disease and asthma [14]. 
3.1.4 Haemotrophic mycoplasmas and M. suis 
HM live and replicate on red blood cells of their host and are not cultivable in vitro. In 
1928 Schilling detected the presence of ring shaped structures on mouse 
erythrocytes and identified them as organisms named Eperythrozoon coccoides 
(Greek: “spherical animal on red blood cell”) [15]. The existence of E. wenyonii in 
cattle and E. ovis in sheep and goats was reported in 1934 and 1943, respectively 
[16, 17]. In 1950 Splitter described a new species of erythrocyte-associated parasites 
in pigs, Eperythrozoon suis [18]. In the meantime similar pathogens have been 
described in cats (Haemobartonella felis) [19, 20], dogs (H. canis) [21] and rats 
(H. muris) [22]. Historically, the differentiation of the genus Eperythrozoon from 
Haemobartonella based on phaenotypic characteristics. In contrast to 
Haemobartonella cells Eperythrozoon members can appear ring shaped. 
Additionally, Eperythrozoon cells appeared as well free floating in the plasma 
whereas members of the genus Haeobartonella always were attached to the red 
blood cell. A species differentiation due to these characteristics was then considered 
as arbitrary [23]. Based on 16S rDNA sequencing, members of the genera 
Eperythrozoon and Haemobartonella were reclassified in 2001 to the genus 
Mycoplasma [4, 24, 25]. 
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HM exhibit distinct species specificity and have been described to occur in several 
animal species, i.e. cats (M. haemofelis, Candidatus M. haemominutum, Candidatus 
M. turicensis) [26, 27], dogs (M. haemocanis, Candidatus M. haematoparvum) [28, 
29], mice (M. coccoides, M. haemomuris) [4, 30], rats (M. haemomuris) [4], reindeers 
(Candidatus M. haemotarandirangiferis) [31], cattle (M. wenyonii) [32], sheep and 
goats (M. ovis) [33], opossums (Candidatus M. haemodidelphis) [28], llamas 
(Candidatus M. haemolamae) [28], squirrel monkeys (Candidatus M. kahanei) [34] as 
well as in pigs (M. suis) [4]. Further, the occurrence of HM in human beings was 
reported [35-37]. In one case, a HIV positive Brazilian patient was found to be 
infected with M. felis. The other two papers describe the situation in China. Between 
1994 and 2007 12840 cases of human beings infected with haemotrophic 
mycoplasmas were registered. One study reports a M. suis prevalence of 35.3 % in 
the local population of Inner Mongolia. Among these population 57.0 % of pregnant 
women and all their newborn babies were tested positive.  
HM are intimately associated with their host cell and are only separated from its 
membrane by an electron lucent zone of about 30 nm width. They are connected by 
fibril structures made of so far unknown proteins [38]. Recently, M. suis has been 
described to be able for cell invasion [39] (Figure1). Figure 2 shows Mycoplasma suis 
cells on red blood cells. 
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Figure 1 Invasion of porcine erythrocytes by M. suis 08/07 shown by scanning electron microscopy 
(B) and transmission electron microscopy (A and C to F). During invasion M. suis 08/07 is located in 
deep invaginations of the RBC membrane (A). As invasion progresses, the erythrocyte membrane 
conforms to the shape of the bacterial cells (A and C), and newly formed membrane material covers 
the surface of the bacteria (B and C). As a result, invading mycoplasmas are located within an 
intraerythrocytic vacuole (D). Intracellular forms that are free in the RBC cytoplasm (E) have a shape 
and size similar to the shape and size of extracellular attached M. suis cells (F). exMs, extracellular M. 
suis; inMs, intracellular M. suis; IS, invasion scar; Ms, M. suis; MsV, M. suis vacuole; RBCC, RBC 
cytoplasm. Figure from [39]. 
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Figure 2 Close association of M. suis cells with porcine red blood cells. A: scanning electron 
micrograph showing a red blood cell infected with M. suis; B: Acridine orange stained blood smear. 
 
The polymorphic bacterium is approximately 200 nm in diameter and harbours a 
circular genome of 0.7 to 0.8 x 109 Da (0.7 to 0.8 kb) that has not been sequenced so 
far [40]. Due to the in vitro unculturability the bacteria are propagated in the 
splenectomised and therefore immunocompromised pig leading to special 
challenges. In all experiments researchers have to deal with the heterogenic porcine 
background in purifications of bacteria. Further, the time point of sampling is often 
difficult to plan. The time course of disease depends on the age of the infected pig 
and the quality of the M. suis inoculum. Despite this fact, eight immunogenic proteins 
were described by our research group [41]. Two of them were characterised in detail. 
MSG1, a protein similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is 
surface localised and involved in adhesion [42]. HspA1, a DnaK–like protein, was 
found by serological proteome analysis and shown to be expressed at the surface of 
M. suis [43]. Both proteins were expressed in E. coli to perform functional studies. 
MSG1 expressing E. coli clones were shown to attach to red blood cells in vitro and 
the purified, recombinant protein exhibited glycolytic activity. The recombinant HspA1 
protein showed ATP activity. Both purified proteins were recognised by convalescent 
sera of M. suis infected animals and therefore were used to establish an ELISA test 
for serological diagnostics [44]. 
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An additional protein i.e. the inorganic pyrophosphatase (PPase) was found by 
M. suis library screening [45]. The activity of the M. suis enzyme was strongly 
dependent on Mg2+ and significantly lower in the presence of Mn2+ and Zn2+. Addition 
of Ca2+ and EDTA inhibited the M. suis sPPase activity. These characteristics 
confirmed the affiliation of the M. suis PPase to family I soluble PPases. The highest 
activity was determined at pH 9.0. In M. suis the sPPase builds tetramers of 80 kDa 
which were detected by convalescent sera from experimentally M. suis infected pigs. 
 
3.2 Anaemia 
The word anaemia is of Greek origin and stands for “lack of blood”. Anaemia is 
diagnosed as diminution of haemoglobin concentration, haematocrit or erythrocyte 
number below the reference values [46]. There are four principle mechanisms for 
anaemia to occur, i.e. (1) deficiency of red blood cell production, (2) increased rate of 
red blood cell destruction or degradation, (3) loss of red blood cells by bleeding and 
(4) circulatory disturbances due to accumulation in enlarged spleen [47]. Patients 
suffering from anaemia often appear pale, feel weak and tired and have problems to 
concentrate. Severe anaemia leads to hypoxia and therefore to dyspnoea [46]. 
3.2.1 Autoimmune haemolytic anaemia 
Human autoimmune haemolytic anaemia (AIHA) shows an incidence of 1:45000 in 
western countries [48]. Patients produce antibodies directed against their own red 
blood cells [49]. In warm AIHA said antibodies are of IgG isotype and reactive at 
37 °C. About 50 percent of warm AIHA are idiopathic, e.g. no underlying disease is 
diagnosed. In contrast, secondary warm AIHA is associated with other illnesses such 
as lymphoproliferative diseases, systemic lupus erythematosus (SLE), intoxications 
or viral infections (e.g. Eppstein Barr Virus, Rubella Virus) [50]. Most IgG antibodies 
recognise the Rhesus complex, which also carriers blood group determinants [51]. 
The expression of autoreactive IgG antibodies is T-cell dependent requiring the 
presence of helper T-cells to induce the class switch from IgM to IgG. An imbalance 
between protecting regulatory T-cells and autoaggressive TH1-cells due to altered 
expression of cryptic epitopes could be responsible for loss of tolerance to host 
proteins [52].  
Additionally, agglutinating IgM antibodies targeting carbohydrate structures 
(I/i epitope) at temperatures below 37 °C, occur. Three forms of cold AIHA have been 
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described, namely spontaneous (seldom, higher risk due to age), idiopathic and 
secondary. Occasionally, the latter develop upon infection with Mycoplasma 
pneumoniae [53]. Nothing is known about a physiological role of cold reactive 
antibodies although very small concentrations of cold agglutinins are present in sera 
of most healthy human beings [54].  
3.2.2 Anaemia in pigs 
In swine, not many triggering factors for anaemia are described. Most common are 
iron deficiency and infectious anaemia of pigs (IAP) caused by infection with M. suis. 
Further reasons for anaemia in pigs include umbilical haemorrhagia, intoxications, 
parasitism and infection with circovirus.  
Acute clinical signs of IAP are accompanied by bacteraemia and include haemolytic 
anaemia, hypoglycaemia, acrocyanosis, icterus, fever and finally death [55]. 
Tetracycline treatment saves the pigs from death but bacteria are not eliminated from 
the host’s body. The disease converts to a chronic state characterised by low-grade 
anaemia, higher susceptibility to other infections, poor reproductive performance of 
sows and growth retardation of piglets. Chronic signs are mainly responsible for 
economic losses caused by IAP. Stress can lead to recrudescence of the disease 
showing above mentioned acute clinical signs but every further “clinical attack” is 
characterised by less severe clinical signs. Usually, pigs infected experimentally with 
M. suis survive from the fourth attack without medical treatment which gives evidence 
for the generation of a protective immune response. Chronically infected animals are 
M. suis carriers.  
IAP is prevalent worldwide and of considerable economical significance for the pig 
industry. A prevalence of 30 percent is reported for the U.S.A. and one of 10 to 30 
percent for China [56, 57]. In Germany, 12 percent of 6 to 8 week old piglets are 
infected [58]. Similar prevalences are expected to occur in Switzerland.  
M. suis cells are passed on to other pigs by transfer of infected blood. This often 
happens iatrogenically. Further, the blood sucking arthropods Stomoxys calcitrans 
(stable fly) and Aedes aegypti have been discussed to play a role as vectors [59].  
One characteristic for anaemia is a low blood haemoglobin (Hb) concentration. The 
reference value for pigs lies between 108 to 148 g/L blood depending on their race 
and age [60]. Pigs suffering from IAP show life threatening anaemia. The lowest Hb 
concentration observed during our studies was 33 g/L. Pigs are pale, icteric and 
show laboured respiration.  
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The knowledge about the pathogenicity of the anaemia in context with M. suis 
infection is sparse. Hoelzle et al. detected the presence of autoreactive antibodies of 
the IgG isotype during the acute phase [41]. Additionally, cold agglutinins occur 
during the chronic phase. In analogy to human cold reactive antibodies induced upon 
infection with M. pneumoniae it is assumed that they target glycosylated proteins on 
the red blood cell membrane [61, 62]. So far, the epitopes have not been 
characterised. Refer to Figure 3 for illustration. 
 
 
Figure 3 Visualisation of cold agglutinins. A: Pig with cyanosis at the ear tips. Red blood cells are 
agglutinated in the peripheral capillaries where body temperature is lower than 37 °C. B: EDTA 
anticoagulated blood incubated at 4 °C and C: at 37 °C. The agglutination is reversible. 
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3.3 Eryptosis 
The normal life span of a human red blood cell is about 120 d. After this time, the cell 
is removed from circulation by macrophage uptake. Due to lack of nucleus and 
mitochondria it was assumed that red blood cells were not able for controlled cell 
death. However, erythrocyte senescence is characterised by conformational changes 
as cell shrinkage, plasma membrane microvesiculation, change in shape from 
discocyte to a sphaerocyte, cytoskeleton alterations associated with protein (spectrin) 
degradation and loss of plasma membrane phospholipid asymmetry leading to 
externalization of phosphatidyl-serine (PS, Figure 4) [63, 64]. In 2001, two 
independent groups described that mature erythrocytes can undergo apoptosis-like 
cell death [65, 66]. In analogy to apoptosis this process was referred to as eryptosis 
[67].  
 
Figure 4 Mechanisms and signaling pathways involved in eryptosis i.e. cellular shrinkage, 
phosphatidylserine exposure and activation of calpains. COX, cyclooxygenase; GSH, reduced 
glutathione; GARDOS, potassium channel; LPAT, lyso-PAF acetyl transferase; NSC, nonselective 
cation channel; PAF, platelet-activating factor; PGE2, prostaglandin E2; PLA2, phospholipase A2. From 
[68]. 
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Similar mechanisms occur in malaria patients. By invading red blood cells plasmodia 
try to evade the immune system of the host. They induce host expression of cation 
channels in erythrocyte membranes to ensure availability of Na+ and Ca2+ ions and 
the possibility of waste disposal. This leads to accumulation of Ca2+ ions in the cells 
and consequently to induction of eryptosis. By this defence mechanism, stressed, 
pathogen-invaded cells are removed from the circulation system without haemolysis 
[69]. Further, the occurrence of eryptosis in sepsis patients has been described [70]. 
Red blood cells obtained from healthy donors underwent eryptosis after incubation in 
plasma from these patients. The authors identified sphingomyelinase-induced 
accumulation of intraerythrocytic ceramide as triggering factor for PS exposure.  
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4. Objectives and Contents 
This thesis deals with the elucidation of pathogenesis of the severe infectious 
anaemia (IAP) of M. suis infected pigs. A combination of at least three mechanisms is 
involved: (I) autoimmune processes, (II) controlled cell death of red blood cells 
(eryptosis) and (III) lysis due to damage by the close interaction of M. suis and the 
red blood cell. In this thesis, the analysis was approached considering changes on 
both sides, i.e. on the host (swine) and on the pathogen (M. suis).  
4.1 Analysis of host’s response 
In response to infection immunological processes are induced to fight invaders. 
Normally, specific antibodies are produced to protect the host. Against that, immune 
responses are misregulated and directed against host structures in M. suis infected 
pigs. In this thesis, analysis of such autoreactive antibodies and identification of 
autoantigens were a central topic. 
Stressed or damaged body cells often undergo apoptosis to prevent inflammation. 
Erythrocytes are able for controlled cell death by a process termed eryptosis. In this 
thesis the occurrence of eryptosis was evaluated to better understand host defence 
mechanisms and to resolve its the impact on the pathogenesis of the anaemia. 
4.2 Analysis of pathogenicity factors 
Lysis of erythrocytes due to direct damage by attachment and invasion processes of 
M. suis is quite evident. Observable deformations, invaginations and invasion 
scarves are generated on the infected red blood cells. Therefore, detection and 
analysis of pathogenic factors as proteins used for attachment, invasion or antigenic 
variation of M. suis were a main issue of this doctoral thesis.  
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5. Results and Methods 
This chapter gives an overview about the results obtained during this Ph.D. thesis 
and the methods used to achieve these results. The methods used in experiments 
that resulted in publications or manuscripts are described in chapter 8. 
5.1 Analysis of host’s response 
5.1.1 Autoreactive antibodies  
Two types of autoreactive antibodies targeting erythrocyte proteins occur during a 
M. suis infection, i.e. IgG warm and IgM cold antibodies. Aim of this thesis was to 
characterise these antibodies. 
IgG warm autoreactive antibodies 
Porcine actin was identified as target of autoreactive warm IgG antibodies by ELISA 
and immunoblots. Actin is recognised mainly during the time points of clinical attacks. 
Details are described in manuscript 8.1. 
IgM cold autoreactive antibodies 
Cold reactive IgM antibodies are upregulated during the chronic state of the disease, 
i.e. when the pathogen load is decreased. In analogy to human IgM cold agglutinins 
induced by M. pneumoniae infection it is most likely that glycosylated proteins are 
targets of cold agglutinins occurring during IAP. Therefore, glycoproteins were 
purified by ether elution [71] (Figure 5). A monoclonal antibody targeting porcine 
Glycophorin A (GlpA), one of the major sialoglycoproteins of the erythrocyte 
membrane, was used to control the presence of GlpA and therefore the quality of the 
purification. Sera containing IgM cold agglutinins were tested of reactivity with these 
glycoprotein purifications by western blot, but no reaction was observed. Therefore, it 
is unlikely that GlpA is a target of cold reactive IgM antibodies induced by M. suis 
infection.  
We decided to enlarge the search for autoreactive antigens to non-glycosylated 
proteins. For this, western blots with whole cell preparations of porcine erythrocytes, 
lymphocytes, murine macrophages and Buffalo Green Monkey cells were performed. 
More bands were reactive on blots if incubated at 4 °C than at 37 °C. Corresponding 
proteins will be identified by mass spectrometry in a planned master thesis project. 
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Figure 5 Purification of glycosylated proteins from porcine erythrocyte membranes. Polyacrylamide 
gels stained with coomassie R-250 for general protein detection (A) and with Schiff-Base for 
glycoprotein detection (B); C: western blot showing porcine GlpA. S: Protein mass standard in kDa. 
 
Methods used for IgM cold reactive antibody characterisation 
 
Purification of cold agglutinins 
To purify cold reactive IgM antibodies, blood samples were put to 37 °C immediately after 
withdrawal to prevent binding of cold agglutinins to the red blood cells. During the 
subsequent clotting process, cold reactive IgM antibodies remained in the soluble serum 
phase. After centrifugation at 2000 x g for 10 min at room temperature, IgM containing serum 
samples were stored in aliquots at -20 °C until use.  
 
Visualisation of cold reactive IgM antibodies 
Animals were observed for acrocyanosis. Blood samples taken at these time points were 
evaluated for reversible cold agglutination of erythrocytes. For this, EDTA blood test tubes 
were incubated at 4°C for 30 min and photographed. Then, samples were exposed to a 
temperature of 37 °C for 15 min and examined for solubilisation of agglutinates. 
 
Western blot 
Sera were used for western blots (as described elsewhere [41]). Briefly, cell preparations of 
Buffalo Green Monkey (BGM) cells, mouse macrophages (J774), porcine erythrocytes and 
lymphocytes as well as M. suis purifications and actin preparations were separated by SDS-
PAGE and transferred to a nitrocellulose membrane. Free binding positions were blocked by 
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2 % (w/v) skim milk in Tris buffered saline (blocking buffer). Next steps (incubation with test 
sera (1:100 in blocking buffer) and with a secondary antibody (1:500 in blocking buffer) 
targeting porcine IgM conjugated to horse-radish-peroxidase (HRP)) were done in parallel at 
4°C and 37 °C over night and for 2 h, respectively. Bound antibodies were detected by 
providing H2O2 as substrate and adding 4-Chloro-1-naphtol for chromogenic development.  
5.1.2 Eryptosis 
Programmed cell death of red blood cells (eryptosis) as response to infection with 
M. suis was evaluated by fluorescence-activated cell sorting (FACS) on a FACS 
Calibur instrument (Becton Dickinson). Preliminary results indicated that severity of 
anaemia and occurrence of eryptosis correlated. A study to further characterise this 
finding was designed and performed. Animals were splenectomised and infected with 
M. suis. Eryptosis occurrence and haematological parameters were recorded over 
the time course of infection. Serum and plasma of an M. suis infected pig was shown 
to induce eryptosis in vitro. Detailed description of methods and obtained results are 
given in manuscript 8.2. 
  
Ph.D. Thesis, Kathrin Felder 
 
19 
 
5.2 Analysis of pathogenicity factors 
5.2.1 Adhesion protein MSG1 
For a pathogen, a prerequisite for infection of a host cell is the capability for 
attachment. We identified an immunogenic protein of M. suis that is involved in the 
attachment process. The GAPDH homologous protein was recombinantly expressed 
in E. coli. This protein exhibited glycolytic activity and was expressed at the surface. 
It was referred to as MSG1 (M. suis glycolytic protein 1). The full length paper is 
presented in chapter 8.3. 
The intimate interaction of M. suis with the red blood cell leads to severe 
deformations and damage at the host cell membrane. If the impairments are strong 
enough cell lysis and consequently anaemia occurs. Knowledge about the interaction 
partner(s) of MSG1 on the red blood cell would help to develop therapy or 
immunisation strategies based on inhibition of attachment. In this thesis receptor 
studies were performed and porcine actin was identified as potential receptor protein 
for MSG1. This finding was confirmed by inhibition ELISAs and surface plasmon 
resonance.  
By ligand blots two proteins of the red blood cells that are bound by MSG1 were 
detected and identified as porcine catalase and cytoskeletal actin (β-actin), 
respectively. A representative blot is shown in Figure 6. 
To show specificity of binding, the interaction was competitively inhibited by adding 
actin during incubation. This analysis was done by ELISA. As indicated in Figure 7, a 
significant inhibition was observed. 
Additional proof for a specific interaction of MSG1 with actin was obtained by surface 
plasmon resonance (SPR). Two experiments were performed. Once, porcine α-actin 
was the bait and MSG1 the analyte. The second experiment was conducted vice-
versa (α-actin was used as analyte and MSG1 as ligand). A tendency for specific 
interaction could be observed for both experiments. The binding was very weak due 
to low concentrated protein purifications.  
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Figure 6 Interaction of MSG1 with porcine proteins on a ligand blot. A: porcine α-actin, B: bovine 
catalase, C: porcine ECL, S: protein mass standard in kDa. Arrows show two protein bands that were 
identified as porcine catalase and β-actin, respectively. 
 
 
 
 
Figure 7. Inhibition ELISA showing the specificity of binding between MSG1 and porcine actin. The 
binding of biotinylated MSG1 to actin is competitively inhibited by incubation in presence of actin. BSA 
does not inhibit the binding. 
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Methods to analyse interaction of MSG1 with host proteins 
Ligand blot 
Purified erythrocytes of healthy pigs were lysed by ice cold hypotonic phosphate buffer 
(5 mM Na2PO4, 1 mM EDTA, pH 7.6) for 5 minutes on ice and centrifuged at 30000 x g for 
15 min at 4 °C. This white pellet was resuspended in lysis buffer and the centrifugation step 
repeated until the pellet appeared white. The white pellet was resuspended in cold 1xPBS to 
a concentration of 1 mg/ml, stored at -80 °C until further use and designated as erythrocyte 
lysate (ECL). 
ECL was separated by SDS PAGE and blotted to a nitrocellulose membrane. The 6xHis 
tagged recombinant MSG1 protein was purified by nickel affinity chromatography and 
biotinylated by the biotin labeling kit (Roche) according to the manufacturer’s 
recommendations. 100 mg of biotinylated MSG1 was incubated with the previously blocked 
membrane (1% FKS in Tris buffered saline; 1xTBS: 50 mM Tris base, 150 mM NaCl, pH 7.6). 
After stringent washing with 1xTBS containing 0.05 % Tween 20, bound protein was 
detected with peroxidase labelled streptavidin. H2O2 was used as substrate and 4-Chloro-1-
naphtol as chromogenic agent.  
The proteins of interest were identified by matrix assisted laser desorption ionisation-time of 
flight coupled to tandem mass spectrometry (MALDI-TOF MS/MS). The analysis was 
performed by Toplab, Martinsried, Germany. 
 
Inhibition ELISA 
100 ng of porcine α-actin were coated to individual wells of 96 well microtiter plates. After 
blocking the free binding positions (1% FKS in 1xPBS, 30 min, room temperature) incubation 
was performed with different concentrations of biotinylated MSG1 for 2 h. For inhibition, 
10 ng of α-actin were added per well during incubation. As a negative control, 10 ng of BSA 
were added. 
 
Surface plasmon resonance (SPR) 
SPR allows the analysis of binding properties between two proteins. A bait protein (ligand) is 
coupled to a matrix (gold) and surface plasmons (electromagnetic waves propagating in 
parallel to the gold interface) are allowed to pass it until a steady state is reached. Then the 
prey (analyte) is added. Upon binding, the surface and therefore the wavelength of the 
surface plasmon, changes. The reflection angle of a light beam directed to the surface 
plasmon is as well changed and can be recorded (response units = RU). The analyte then is 
removed from the ligand. From the signals association (von) and dissociation rates (voff) are 
determined. The dissociation constant then can be calculated by Kd=voff/von.  
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Figure 8 illustrates the principle of the SPR method. The experiments were done with Stefan 
Schauer in the functional genomics centre, Zurich, with the Biacore T100 instrument (GE 
Healthcare). 
 
 
 
 
Figure 8 Principle of Surface Plasmon Resonance (SPR). A light beam hits a surface plasmon. The 
detected emission angle changes if the surface plasmon changes by encountering a different surface 
structure. A typical association and dissociation signal of a SPR binding assay between ligand and 
analyte is shown in the sensorgram. 
(http://www.rci.rutgers.edu/~longhu/Biacore/MolecularInteractionAnalysis.html). 
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5.2.2 Immunogenic adhesion protein MSG1 as vaccine candidate 
MSG1 was evaluated for the potential of acting as protective immunogen. 
Unfortunately, no significant protection was observed. During this experiment, some 
animals showed clinical signs that were more severe than usual. These animals had 
to be put out of their misery by euthanasia. It was not clear, whether immunisation 
with MSG1 worsened symptoms instead of being protective. For details refer to 
publication 8.4. 
5.2.3 Proteomic analysis to detect further M. suis proteins 
Of particular interest were proteins that could be involved in pathogenesis of 
anaemia. We decided to use liquid chromatography coupled to mass spectrometry 
(LC-MS). Proteins are roughly separated by conventional SDS-PAGE and peptides of 
interest are further separated by liquid chromatography and identified by mass 
spectrometry. Compared to separation by means of two dimensional gel 
electrophoreses the method requires lower amounts of protein.  
To identify proteins a database containing all published protein sequences of species 
classified as Mollicutes was created and the identified peptides were compared to 
these sequences. Using the uniref100 database of the European Bioinformatics 
Institute, peptides of porcine origin could be recognised and were neglected. In 
Figure 9 a representative gel is shown and Table 1 gives an overview of detected 
proteins. The genome of M. suis has not been sequenced so far, therefore, only the 
sequences of MSG1 and HspA1 could be considered in the database. In all M. suis 
containing samples the two M. suis proteins were clearly identified. For other proteins 
we were dependent on cross-species identification. Mycoplasmas generally show low 
homologies between different species, both on DNA and on protein level. 
Consequently, the proteins could not be identified definitely. However, 21 of found 
proteins were confirmed on genomic level in context with a concomitant Ph.D. study 
that deals with sequencing of a shot gun M. suis library (Table 1).  
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Figure 9 Coomassie stained gel showing separation of M. suis proteins for LC-MS sample 
preparation. S: Molecular weight standard in kDa, M: M. suis purification. The gel was fragmented 
according to the horizontal bars prior to digestion with trypsine. 
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Table 1 Proteins identified by LC-MS/MS of species of the taxonomic Class Mollicutes. The two 
M. suis proteins are shaded. By screening a shot gun library of M. suis some genes were sequenced. 
The right column indicates if protein identification could be confirmed (√) on genomic level. 
Protein Species M. suis 
30S ribosomal protein S2 M. gallisepticum  
3-dehydroquinate synthetase Acholeplasma laidlawii  
60 kDa chaperonin M. genitalium  
ABC transporter, ATP binding 
protein M. penetrans  
ABC transporter, permease 
protein M. agalactiae √ 
ABC-type amino acid transport 
system, permease component Onion yellows phytoplasma √ 
Appendage associated protein 
precursor Anaplasma marginale  
Arginyl-tRNA synthetase M. agalactiae  
Aspartyl-tRNA synthetase M. hyopneumoniae √
ATP dependent protease La M. agalactiae, Aster yellows witches’-broom phytoplasma √ 
ATP synthase subunit B 
M. penetrans, M. pulmonis, M. mobile, M. 
synoviae, M. hyopneumoniae, Mesoplasma 
florum 
√ 
Beta-ketoacyl-(acyl carrier 
protein) synthetase Acholeplasma laidlawii  
Cell division protein ftsZ M. genitalium √
Chaperone protein dnaJ M. mycoides subsp. mycoides SC  
Chaperone protein dnaK 
M. pulmonis, M. gallisepticum, M. 
hyopneumoniae, Anaplasma marginale, 
Mesoplasma florum 
√ 
Chromosome segregation 
ATPase Mesoplasma florum  
Cytadherence high molecular 
weight protein 1 M. genitalium  
Cytadherence high molecular 
weight protein 2 M. pneumoniae  
Cytoskeletal protein M. penetrans  
degV family protein M. capricolum subsp. capricolum ATCC 27343  
Dihydrolipoamide 
dehydrogenase M. synoviae, M. agalactiae  
DNA directed RNA 
polymerase subunit beta 
M. penetrans, M. gallisepticum, M. capricolum 
subsp. capricolum, U. parvum, M. pulmonis, M. 
genitalium, M. hyopneumoniae, M. mycoides 
subsp. mycoides SC, Spiroplasma citri 
√ 
DNA polymerase III alpha 
subunit M. synoviae  
DNA polymerase III subunits 
gamma and tau M. hyopneumoniae  
DNA processing protein smf M. mobile  
DnaA M. gallisepticum  
DppD M. gallisepticum  
Elongation factor G M. genitalium, M. gallisepticum, M. agalactiae, M. penetrans, M. mobile √ 
Elongation factor Tu M. hominis, Mesoplasma florum, Apple  
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Protein Species M. suis 
proliferation phytoplasma 
Endoglucanase M. synoviae  
Fructose-bisphosphate 
aldolase M. synoviae, M. pulmonis  
Glucose-6-phosphate 
isomerase 
M. agalactiae, Aster yellows witches’-broom 
phytoplasma  
Glyceraldehyde-3-phosphate 
dehydrogenase M. pneumonia, Onion yellows phytoplasma √ 
Glycerol-3-phosphate 
dehydrogenase M. mobile  
HspA1 M. suis √
HtpA Mycoplasma phage MAV-1  
Hystidiyl-tRNA synthetase M. mobile √
Integral membrane protein M. penetrans, Mesoplasma florum  
Leucyl-tRNA synthetase M. penetrans, M. capriculum subsp. capricolum √
Lipoate-protein ligase A Onion yellows phytoplasma  
Lipoprotein M. capricolum subsp. capricolum  
Lysophospholipase M. mycoides subsp. mycoides SC  
Membrane-anchores GGDEF 
domain protein Acholeplasma laidlawii  
Membrane-bound ATP-
dependent metalloprotease Acholeplasma laidlawii  
Methionyl-tRNA synthetase M. penetrans √
MSG1, g1 adhesin M. suis √
Mg2+ ion transporter U. parvum √
Na+ ABC transporter, ATP 
binding component M. mycoides subsp. mycoides SC √ 
NADH oxidase Mesoplasma florum  
Phenylalanin-tRNA synthetase 
beta chain M. pulmonis  
Phosphatidate 
cytidylyltransferase M. agalactiae  
Phosphoenolpyruvate-protein 
phosphotransferase enzymeI 
M. mobile, Acholeplasma laidlawii, M. mycoides 
subsp. mycoides SC, M. hyopneumoniae √ 
Phosphoglyceromutase Mesoplasma florum √
Prolipoprotein M. mycoides supsp. mycoides SC  
Prolipoprotein B M. mycoides subsp. mycoides SC  
Pseudogene of transposase 
(C-terminal) M. agalactiae  
Pseudouridine synthase B M. mobile  
Phase-variable hemagglutinin, 
putative M. synoviae  
Pyruvate kinase M. hyopneumoniae  
RecA M. pneumoniae √
Ribosome binding factor A M. genitalium, M. pneumoniae  
Ribosome recycling factor M. genitalium  
Topoisomerase 1 M. gallisepticum  
Topoisomerase IV subunit B M. hyopneumoniae  
Translation inititation factor IF-
2 Aster yellows witches’-broom phytoplasma  
Type I restriction enzyme r 
protein M. mobile  
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Methods used for proteome analysis 
Sample preparation 
Freshly drawn red blood cells with attached M. suis cells were washed 3 times in 1xPBS to 
remove plasma proteins. The red blood cells were diluted in a 1:1 ratio (v/v) in 1xPBS and 
incubated for two hours at 37 °C. By this procedure the M. suis cells detach from their host 
cells. Then, red blood cells were removed from the samples by low speed centrifugation 
(200 x g, 5 min). The supernatant was mixed with 2x SDS PAGE sample buffer (0.15 M Tris, 
pH 6.8, 1 % SDS, 30 % Glycerol, 15 % β-mercaptoethanol, 0.002 % bromophenol blue) in a 
ratio of 1:1 (v/v) and boiled for 5 min. Samples were loaded on 10 % polyacrylamid gels and 
proteins were electrophoretically separated according to their mass. Gels were incubated for 
1 h in fixation solution (40 % ethanol, 10 % acetic acid) and stained with colloidal coomassie 
G-250 over night. The staining solution consisted of 10 % w/v (NH4)2SO4, 20 % w/v ortho-
phosphoric acid, 25 % v/v methanol, 6 % w/v coomassie brilliant blue G-250. 
 
Tryptic digest 
The gel was sliced to 8 pieces, distained (incubation in 50 % methanol in 100mM NH4HCO3, 
pH 8.0 for 3 h at 37 °C) and each gel piece was digested with trypsine (0.001 % trypsine in 
5 mM Tris, pH 8.0, 6 h at 30 °C). Peptides were extracted from the gel by means of 0.1 % 
and 10 % (v/v) formic acid (FA) and concentrated by an Eppendorf Speedvac centrifuge. 
Peptides were resolved in a buffer containing 5 % (v/v) Acetonitrile (ACN) and 0.1 % (v/v) 
FA. Samples then were desalted using C18-ZipTips (Millipore). 
 
Peptide identification 
Analysis of peptides was done by liquid chromatography coupled to mass spectrometry (LC-
MS/MS) in the functional genomics centre (FGCZ) by Bernd Roschitzki as described in [72]. 
Briefly, samples were resuspended in 5% v/v ACN, 0.2% v/v FA (Buffer A) and loaded onto a 
reverse-phase capillary column (RP C18, 75 mm_8 cm; 200A, AQ; Bischoff GmbH) using a 
fully automated nanoflow LC system consisting of a PAL autosampler (CTC Analytics AG) 
and a binary Rheos 2000 pump (Thermo Scientific). Liquid chromatography was performed 
using a 90-min gradient by means of Buffer A and B (80% v/v ACN, 0.2% v/v FA). Peptides 
were eluted with the following linear gradient: 0–3 min, 0% solvent B; 3–53 min, 0–50% 
solvent B; 53–63 min, 50–100% B followed by 100% B for 4 min and 100% A for 23 min. The 
LC system was directly coupled to an ion trap mass spectrometer, equipped with a 
nanospray ionization source (LTQ ESI Trap, ThermoScientific). Each MS full scan was 
followed by the acquisition of up to three data-dependent MS/MS spectra of the three most 
intense peaks. Parent masses used for MS/MS were dynamically excluded for 0.5 min.
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6. Discussion 
6.1 Analysis of host´s response 
Infectious anaemia of pigs (IAP) is of economic significance due to a prevalence of 
10 to 30 percent in Western countries. Animals show growth retardation, are 
susceptible to other infections and sows show reduced fertility. A main clinical sign in 
acutely ill pigs is the severe anaemia that occurs upon stress. Knowledge about the 
pathogenesis of this anaemia is rare due to drawbacks in research. These include 
the unculturability of M. suis and the dependency on the pig as propagation vessel 
which leads to background of porcine DNA or protein in all samples. It is evident, that 
several mechanisms collude in generation of anaemia in a complex way. Among 
these are autoreactive processes, programmed cell death and direct red blood cell 
lysis by interaction with M. suis. 
There are two types of autoreactive antibodies involved in M. suis infection. IgM cold 
agglutinins occur during later stages of infection leading to acrocyanosis and 
consequently necrosis of harmed tissues. Target structures are not identified. In 
analogy to human cold agglutinin disease induced by M. pneumoniae it is assumed 
that glycoproteins on the erythrocyte membrane are recognised [61, 62]. In this 
dissertation, the reactivity of these antibodies with a glycoprotein purification of red 
blood cells was tested but no reactivity was observed. The quality of the glycoprotein 
purification was controlled with a monoclonal antibody targeting Glycophorin A 
(GlpA), a protein that is present in high amounts on membranes of red blood cells. 
Probably, glycoproteins of lower abundance were too low concentrated to be 
detected in the glycoprotein purifications used. However, some reactive bands were 
obtained in western blots with whole cell preparations conducted at 4 °C. Cold 
agglutinins are responsible for the milder anaemia developing in the chronic phase of 
the disease.  
In contrast, there are autoreactive antibodies of the IgG isotype [41]. They are 
upregulated during the acute phase of IAP. In this thesis, actin was identified as a 
target. In eukaryotes there are three types of actin, i.e. α-actin, β-actin and γ-actin. 
The autoreactive IgG antibodies recognise α-actin and β-actin; however, there is a 
preference for β-actin. This actin form is present in cytoskeletons of eukaryotic cells, 
including the red blood cell.  
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An upregulation of autoreactive antibodies is the consequence of loss of tolerance to 
self antigens. Actin, that usually is cryptic, gets accessible for immune cells by 
interaction of M. suis with the red blood cell. Upon attachment, the plasma membrane 
is damaged and gets permeable for antibodies. The finding, that MSG1 and actin 
interact in vitro supports this theory. M. suis maybe is able to dissolve the plasma 
membrane by enzymatic activity. Further, there is evidence that actin is rearranged 
by invasion of M. suis [39]. Changed host proteins are no more recognised as self 
which leads to activation of an adaptive specific immune response directed against 
host actin.  
Actin recognising B-cells are present in healthy organisms and are necessary for 
tissue homeostasis [73]. Due to an unspecific mitogenic stimulus induced by M. suis 
infection, B-cells recognising actin could be stimulated by a thymus independent 
mechanism (Ti-immune reaction) [62]. The fact that mycoplasmas can activate B-
cells without regard to antigen specificity was described to occur for several 
Mycoplasma species, e.g. M. pulmonis, M. arginini, M. fermentans or M. pneumoniae 
[74-77]. To further elucidate the role of this unspecific blastogenesis in context with 
M. suis infection further studies are required.  
A widespread mechanism for induction of autoreactivity in context with infections is 
molecular mimicry. This means that a pathogen shares an epitope with a host 
protein. To find potential epitopes special algorithms, i.e epitope finder programs 
have been developed. For swine lymphocyte antigens (SLA) the NetMHCpan 
program is available [78]. By feeding the sequences of porcine β-actin and M. suis 
MSG1 into the program, a potentially cross-reactive epitope was found. The peptides 
LTLKYPIEH and RTLKYYISL derived from β-actin and MSG1, respectively, are 
theoretically presented by the SLA-2*0201 molecule to circulating T-cells. Due to 
degeneracy of both, the T-cell receptor and the MHC peptide-binding motifs, the 
identity of 55 % of these two proteins theoretically is enough for cross-reactivity [79, 
80]. Interestingly, clinical signs are only observed in the blood circulation system. If 
the actin present in muscle cells would be targeted, corresponding clinical signs 
would be expected. This substantiates the theory that M. suis has to be locally 
present to induce autoreactive antibody formation.  
So far, M. suis cells as well have been exclusively found inside the circulatory 
system. It is not clear why the bacterium selected the red blood cell as its habitat. On 
one hand, this cell type is small, does not harbour many nutrients, does not 
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synthesise any proteins, is not stationary and has a limited life span of about 120 
days. But on the other hand, red blood cells are the only body cells lacking MHC I 
molecules. This allows intracellular pathogens to evade the immune response 
mediated by cytotoxic T-cells. Additionally, the erythrocyte harbours high 
concentrations of iron bound to haemoglobin and of glucose. Glucose levels were 
shown to be negatively correlated to M. suis loads [81]. An obvious explanation was 
that bacteria consume the glucose directly. It was reported that red blood cells 
infected with Plasmodia exhibited a 40 to 100 times higher glucose consumption rate 
compared to uninfected cells [82]. For M. suis infection of porcine red blood cells it 
remains to be elucidated whether M. suis, the infected red blood cell or both together 
are responsible for glucose level diminution in the blood.  
In any case, the integrity of the infected red blood cell is challenged. Upon stress a 
suicide program is started and the single cell sacrifices itself in favour of the whole 
organism. This process, referred to as eryptosis, can therefore be defined as defence 
mechanism against intracellular pathogens. If high numbers of cells get infected, 
eryptosis can be responsible for triggering anaemia. In blood samples of M. suis 
infected animals higher amounts of PS exposing red blood cells were detected than 
in samples of healthy pigs. A negative correlation of eryptotic cell number to 
haematocrit levels was recorded during the growth phase of M. suis cells indicating a 
causal interrelation. In this phase, the anaemia seems to be induced by programmed 
cell death of erythrocytes. During maximal bacteraemia the red blood cells were not 
stained anymore with PKH-26, a membrane dye that exclusively stains cells with 
intact cell membranes, i.e. healthy and eryptotic cells. It is evident that another 
mechanism of cell death (intravascular haemolysis due to autoreactive antibodies or 
direct damage by the bacterium) took over. At this time-point, when loads of up to 
4000 M. suis cells per red blood cell were recorded, the mechanism of eryptosis to 
protect the organism simply was exhausted. However, proof for eryptotic activity even 
at this time point is given. Incubation of red blood cells from healthy pigs with serum 
or plasma taken during bacteraemia led to breakdown of membrane asymmetry in 
vitro. The serum and plasma samples contained M. suis cells. Therefore, it has to be 
elucidated whether the triggering factor is M. suis or a soluble compound in the 
plasma. 
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6.2 Analysis of pathogenicity factors 
Due to their small genome mycoplasmas are not able to synthesise all essential 
molecules. This leads to a close association with and a dependency on their host 
cell. By this intimate contact, changes on the host cell are inevitable. This could, as 
mentioned above, lead to actin rearrangements. From another intraerythrocytic 
organism namely Plasmodium falciparum it is known that it induces the expression of 
ion channels in the plasma membrane of the red blood cell for acquisition of Ca2+ and 
Na+-ions and disposal of waste products [82, 83]. An elevation of Ca2+ influx leads to 
breakdown of membrane asymmetry by exposure of phosphatidyl-serine (PS) 
residues to the outer leaflet [84]. The same happens in normal erythrocyte 
senescence. The exposed PS of an old red blood cell are recognised by 
macrophages and the cell is safely removed from the circulation system without 
causing inflammation [64]. At a first glance, eryptosis is unfavourable for an 
intracellular pathogen. However, exposed PS leads to attachment to vascular 
endothelial cells and therefore offers the opportunity of settledness [85].  
M. suis infection of red blood cells leads to severe deformations. To invade the cell, 
bacteria manipulate the membrane. If this is done excessively, the membrane 
integrity is broken and the cell is lysed leading to anaemia. To get knowledge about 
mechanisms causing cell lysis it is important to identify pathogenicity factors as 
attachment proteins and proteolytic enzymes. One attachment protein, the MSG1, 
was identified, purified and characterised [42]. The immunogenic protein is analogous 
to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and expressed at the 
surface of M. suis. In vitro it interacts with porcine actin. Cytoskeletal actin lies inside 
the plasma-membrane of cells and therefore is not directly accessible. Thus, M. suis 
must have additional tools to protrude the membrane. To find such pathogenicity 
factors an attempt of analysing the proteome of M. suis was carried out. This was 
hampered due to unavailability of genome data of M. suis. Therefore, the peptides 
were compared to protein sequence data of other members of the taxonomical class 
of the Mollicutes. Within the genus Mycoplasma homologies in genome and 
proteome data are low. For instance, the identity of the genes encoding glucose-6-
phosphate isomerase of M. penetrans and M. synoviae is only 46.1 %. On protein 
level, the identity score is 39.1 % and the similarity score 61.4 %. Due to the 
dependency of cross-species identification the scores in our analyses were very low 
(between 20 and 70 %) and the identifications therefore not secure. Proteomics 
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specialists expect an identity score of > 95 % for a positive identification of a protein. 
However, some promising preliminary data were obtained and genome sequencing 
data of shot gun library clones endorsed the protein identifications in 21 cases. 
Generally, Mycoplasma proteins exhibit multiple functions due to the small genome 
sizes. For example, proteins involved in the carbohydrate metabolism have been 
described to act as virulence factors [42, 86]. Eight of the identified proteins in 
Table 1, including MSG1 of M. suis, are involved in sugar metabolism. Additionally, 
there were two cytadherence proteins and a putative phasevariable hemagglutinin. 
These proteins are involved in pathogenicity. It was shown that loss of cytadherence 
protein function in M. pneumoniae led to non-adherent growth and loss of cytotoxicity 
[87]. Hemagglutinis are lipoproteins that cause red blood cells to agglutinate. An 
example is VlhA of M. synoviae, a protein used for attachment to the erythrocyte [88]. 
Loss of hemagglutinin function leads to apathogenicity [89]. In order to confirm these 
identifications and to find additional M. suis proteins, the identified peptides will be re-
analysed as soon as the genome data are available. 
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7. Milestones and Outlook 
The pathogenesis of the anaemia induced by M. suis infection is due to a complex 
interplay of several mechanisms. During this thesis some aspects were clarified, i.e. 
the occurrence of autoreactive antibodies targeting porcine actin and the 
upregulation of eryptotic processes. Additionally, evidence for several pathogenicity 
factors was found. For the attachment protein MSG1 a potential receptor on the red 
blood cell was identified, i.e. porcine actin. Figure 10 gives an overview of the 
involved mechanisms. 
 
 
 
Figure 10 Overview about the pathogenesis of the haemolytic anaemia in pigs due to M. suis 
infection. A complex interplay of several factors originating from the host as well as from the pathogen 
is taking place. The pale pig suffers from anaemia that is induced by autoreactive mechanisms, 
eryptosis and direct haemolysis due to damages resulting from attachment and invasion processes of 
mycoplasmas.   
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The experiments performed during this dissertation elucidate aspects of the anaemia 
pathogenesis and are the basis for clarification of further questions.  
o The host immune system plays a crucial role for the outcome of the disease. 
Clarification of the involved mechanisms therefore was and still is a main topic 
in our research group. This includes the detection of target epitopes of cold 
agglutinins and the elucidation of the mechanisms involved in autoreactivity. 
Mycoplasmas are able to interfere with the host’s immune system e.g. by 
providing mitogenic stimuli on unrelated B-cells. Thereby, the specific immune 
response against M. suis is masked due to an excess of antibodies that 
recognise non-mycoplasmic structures. 
 
o A further strategy to evade the host’s immune response is antigenic variation. 
To explore the ability of M. suis for antigenic variation the expression profile 
during the time course of infection is observed by proteome analysis. In 
parallel, changes in expression of pathogenicity factors are recorded. 
 
o Immune evasion is achieved by hiding in the red blood cells that lack MHC I 
molecules. Infected cells therefore are not recognised by the immune system. 
The only mechanism left to safely remove the infected cell is programmed cell 
death. In fact, the majority of red blood cells are infected during bacteraemia. 
Clearance of these cells therefore aggravates the anaemia. Additionally, 
eryptotic cells exhibit PS residues at their surface mediating the ability for 
attachment to endothelial cells which leads to circulatory disturbances. Thus, 
future experiments deal with clarification of the triggering factors for eryptosis. 
 
o In vitro experiments indicate that MSG1 binds porcine actin. All experiments 
considering actin and MSG1 interaction were performed with muscular actin 
(α−actin) of the pig. Red blood cells as well as other body cells predominantly 
contain the cytoskeletal actin form (β-actin). However, this protein was 
commercially not available. Therefore, it was expressed in E. coli. Additionally, 
fragments of β-actin are produced to identify the actual binding regions of 
actin.  
 
Ph.D. Thesis, Kathrin Felder 
 
35 
 
o The obtained proteome data indicate the presence of several pathogenicity 
factors of M. suis. Due to lack of genome data the identification scores were in 
general too low for acceptance in the scientific community. Currently, a 
genome sequencing project is running. M. suis DNA was separated from 
porcine DNA by selective digestion of the porcine DNA and sequenced by the 
454 method developed by Roche. The obtained sequences are currently 
annotated. With these data at hand additional peptides will be identified and 
the proteomic results obtained in this thesis will be confirmed and can be 
published.  
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8. Manuscripts and Publications 
 
In this section, a submitted manuscript, a manuscript prior to submission and two 
peer reviewed publications including results associated with this Ph.D. thesis are 
presented. Own contributions are described for each part. 
 
8.1 Antibodies to actin in autoimmune haemolytic anaemia 
 
Kathrin M. Felder, Katharina Hoelzle, Karl Heinritzi, Mathias Ritzmann, and Ludwig E. 
Hoelzle 
Submitted to BMC Veterinary Research 
In this manuscript we describe for the first time actin as autoantigen in connection 
with autoimmune haemolytic anaemia.  
I cloned and expressed porcine β-actin, performed analysis of sera by ELISA and 
western blot and wrote the manuscript. 
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Antibodies to actin in autoimmune haemolytic anaemia 
 
Kathrin M. Feldera, Katharina Hoelzlea, Karl Heinritzib, Mathias Ritzmannc, and 
Ludwig E. Hoelzlea* 
 
aInstitute of Veterinary Bacteriology, Vetsuisse Faculty, University of Zurich, Switzerland  
bClinic for Swine, Ludwig-Maximilians-University Munich, Munich, Germany 
cClinic for Swine, University for Veterinary Medicine, Vienna, Austria 
 
 
Abstract 
Background: In Autoimmune haemolytic anaemia (AIHA) autoreactive antibodies 
directed against red blood cells are upregulated leading to erythrocyte cell death. 
M. suis infections in pigs (IAP) induce AIHA of both the warm and the cold type. Aim 
of this study was to identify target autoantigens of warm autoreactive IgG antibodies. 
For this, sera from experimentally M. suis infected pigs were screened for 
autoreactivity.  
Results: In sera of 95 % of all tested animals actin-reactive antibodies were found. 
The reactivity was shown to be species specific, i.e. reactivity with porcine actin was 
significantly higher than with rabbit-actin. Sera of animals previously immunized with 
the adhesion protein MSG1 of M. suis showed reactivity with actin prior to infection 
with M. suis indicating molecular mimicry to be involved in specific autoreactive 
mechanism. A potentially cross reactive epitope could be detected.  
Conclusions: This is the first report of autoreactive anti-actin antibodies involved in 
pathogenesis of autoimmune haemolytic anaemia. 
 
 
* Corresponding author: PD Dr. L. E. Hoelzle, Winterthurerstr. 270, CH- 8057 Zurich; 
Phone: 004144658613; Fax: 004144658912  
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Background 
Human autoimmune haemolytic anaemia (AIHA) shows an incidence of 1:45000 per 
year in western countries [1, 2]. 70 % of patients suffer from warm, 15 % from cold 
AIHA. Warm AIHA is characterised by IgG antibodies binding their target epitope at 
body temperature [3]. The target membrane antigen is usually within the Rhesus 
system, although often the antibody specificity cannot be defined [4]. In cold AIHA 
complement activating autoreactive IgM antibodies bind their antigen, usually the l/i 
epitope on red blood cells, below body temperature and are strongly agglutinating at 
4 °C [5, 6]. Cold AIHA is divided into acute and chronic forms. Acute forms often 
occur from between two to three weeks after an infection with mycoplasmas, e.g. 
M. pneumoniae, Epstein-Barr-Virus or Rubella virus [6]. About 50 % of warm cases 
are classified as idiopathic, meaning that no obvious underlying disorder is known. 
For secondary warm AIHA several causes have been identified, i.e. Non-Hodgkin-
Lymphoma, systemic lupus erythematosus, drugs and viral infections. In 7 % of AIHA 
both types of antibodies occur; this is referred to as mixed AIHA. Sokol and co-
workers report only one case of secondary mixed AIHA due to Mycoplasma infection 
[2]. 
Haemotrophic mycoplasmas infect red blood cells of several mammalian hosts [7, 8]. 
Generally, they show distinct host specificity. However, reports on human beings 
infected by haemotrophic mycoplasmas, i.e. Mycoplasma haemofelis and 
Mycoplasma suis have been published [9, 10]. 
M. suis causes infectious anaemia of pigs (IAP) [7]. Within this disease, the presence 
of mixed AIHA was found. IgM cold agglutinins targeting glycoproteins on the red 
blood cells were observed [11, 12]. These cold agglutinins occur about 4 weeks after 
experimental infection with M. suis. During the acute stage of IAP (clinical attack), 
acute anaemia, hypoglycaemia and icteroanaemia accompanied with high mortality 
occur. It is assumed that the severe anaemia observed in pigs suffering from acute 
clinical signs is due to a combination of direct damage of red blood cells by M. suis 
attachment and invasion as well as an upregulation of cold and warm autoreactive 
antibodies directed against red blood cell components. In previous studies, these 
autoreactive warm IgG antibodies were shown to overwhelm the specific immune 
response to M. suis [13].  
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In this study, sera of experimentally M. suis infected pigs were screened for the 
presence of warm IgG antibodies by testing their reactivity with blood preparations of 
healthy pigs. The detection and characterisation of host proteins that served as 
autoantigens was a main issue. Earlier studies, i.e. serological proteome analysis 
[14] rendered some evidence for actin to be a target protein of autoreactive 
antibodies detected during the acute state of the disease. This was observed in one- 
as well as in two-dimensional immunoblots. Therefore, sera tested in this study were 
additionally screened for reactivity with muscular (α-) and cytoskeletal (β-) actin of 
the pig. 
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Results 
Study design and screening of porcine sera for autoreactive antibodies  
A collection of sera obtained from experimentally M. suis infected pigs was available 
from earlier studies [13, 15]. Sera were divided into two groups according to their 
history. Group 1 sera (36 sera) derived from pigs (n=13) that were vaccinated with 
MSG1 prior to splenectomy and challenge with M. suis infection. Due to the known 
main occurrence of autoreactive IgG antibodies during clinical attacks [13] sera used 
for the present study were drawn at following time points: I. 21 days post 
immunisation and 14 days prior to M. suis infection, II. during the first clinical attack 
(on average 10 days after infection), III. 14 days apart, IV. during the second clinical 
attack (on average 6 weeks post infection). Due to death of animals less sera could 
be analysed at time points II (n=11), III (n=6) and IV (n=6). Group 2 sera originated 
from 10 pigs that were not immunised prior to splenectomy and M. suis infection. It 
consisted of 40 sera. For this study sera taken prior to infection (I), during the first 
clinical attack (II), in between the first and the second clinical attack (III) and during 
the second clinical attack (IV) were considered. In total, 76 sera (36 of group1 and 40 
of group 2) were screened by ELISA for reactivity with IgG depleted antigen 
preparations from healthy pigs (neg Ag). OD values were normalised to the negative 
control. The cut-off value was determined to be 0.226 (three times standard deviation 
of negative controls). 
Figure 1a gives an overview of screening results. At time point I, prior to splenectomy 
and infection, 84.6 % of sera of group 1 (immunised with MSG1) and no sera of 
group 2 showed autoreactivity. During the first clinical attack a shift in antibody 
response could be observed. Reactivity of group 1 sera decreased to 45.5 %. 60.0 % 
of group 2 sera reacted with neg Ag. Between two clinical attacks 83.3 % of sera of 
immunised pigs showed autoreactivity, sera of group 2 down regulated antibodies to 
neg Ag completely. During the second clinical attack 100.0 % of sera in group 1 and 
80.0 % of sera in group 2 were autoreactive. Reactivities between groups differed 
significantly at every time point. P values were determined to be ≤ 0.006, 0.010, 
0.004 and 0.043 for I, II, III and IV, respectively. Only for one animal out of 23 no 
autoreactive antibodies were detected in sera taken at any time point. Figure 1b 
shows occurrence of autoreactive antibodies during time course of infection for one 
animal of each group. The vaccinated animal representing group 1 already produced 
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autoreactive antibodies after immunisation with MSG1 and prior to infection and 
splenectomy. Autoreactive antibodies remained on a similar level for time points II, III 
and IV. The animal selected to represent group 2 did not show autoreactive 
antibodies before infection, upregulated antibodies to neg Ag at timepoint II 
(1st clinical attack), down regulated them below the cut-off value between clinical 
attacks and again produced autoreactive antibodies during the 2nd clinical attack (IV).  
Reactivity with porcine α-actin  
In order to identify autoantigens, the found autoreactive sera (n=36) were further 
tested with IgG depleted erythrocyte lysates (ECL) and with porcine α-actin. In earlier 
studies hints for actin as a potential target of warm autoreactive antibodies were 
found (one- and two dimensional immunoblots) [14]. In 32 sera (88.9 %) antibodies 
reactive with both preparations were detected. Linear regression for neg Ag with ECL 
and α-actin revealed R2 values of 0.732 and 0.744, respectively (Fig. 2).  
The actin reactivity was shown to be species specific, i.e. a significant lower reactivity 
was observed with rabbit α-actin than with porcine α-actin. Mean OD values at λ = 
405 nm were 0.408 ± 0.136 and 0.793 ± 0.185 for rabbit- and for porcine α-actin, 
respectively. 
Reactivity with porcine β-actin  
The erythrocyte contains cytoskeletal actin (β-actin). This actin form is highly 
homologous but not identical to the muscular actin (α-actin). Since β-actin was not 
commercially available the gene was synthetically produced and adapted to the 
E. coli codon usage. The protein was expressed, purified and used for the 
experiments (Fig. 3). Sera reactive with α-actin were tested further with β-actin. All 
these sera were positive with both actin forms. For group 1, the MSG1 immunised 
animals, a strikingly stronger reactivity with β-actin than with α-actin was observed 
(P ≤ 0.0002). No significant difference was seen in sera of group 2 animals 
(P ≤ 0.2034).  
Isotypes of autoreactive antibodies to actin  
In warm autoimmune haemolytic anaemia IgG1 and IgG3 antibodies predominate 
[16]. These antibodies are recognised preferably by macrophages. To gain insight 
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into autoreactive mechanisms occurring during a M. suis infection, secondary 
antibodies to porcine IgG1 and IgG2 were used for evaluation of subtypes of actin 
reactive antibodies of group 1. Secondary antibodies to porcine IgG3 were not 
available. The ratios IgG1/IgG2 and IgG2/IgG1 were calculated to be 1.280 ± 1.796 
and 2.727 ± 1.925, respectively (P ≤ 0.018).  
Search for shared epitopes between MSG1 and actin  
Reactivity with actin was observed in MSG1 vaccinated immunocompetent animals 
previous to splenectomy and M. suis infection. To support the hypothesis of 
molecular mimicry, the reactivity of a rabbit hyperimmune serum against recombinant 
MSG1 with actin and vice-versa, i.e. reactivity with hyperimmune serum against 
porcine actin with MSG1 was evaluated. Such cross-reactivity was observed (Fig. 4). 
Therefore, the protein sequences of porcine actin as well as of MSG1 were used as 
input in an epitope finder program. The program allows identifying epitopes 
potentially presented by SLA molecules to B-cells with high probability. SLA-2*0201 
would present the peptide LTLKYPIEH derived from actin and the peptide 
RTLKYYISL derived from MSG1. Both peptides are 9 amino acids in length and 
share a sequence identity of 55 %. This peptide is identical in both actin forms. 
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Discussion 
Autoimmune haemolytic anaemia (AIHA) is an autoimmune disorder characterised by 
autoreactive antibodies directed against an individual's own red blood cells (RBCs) 
leading to enhanced clearance of RBCs by Fc receptor (FcR)-mediated phagocytosis 
[17]. About 50 percent of human warm AIHA cases are idiopathic [18], i.e. no 
underlying disorder is known. Amongst others, conceivable causes of AIHA are 
infectious diseases. There are cases in which AIHA has been associated with viral, 
bacterial or parasitic infectious agents [3, 5]. M. pneumoniae is often involved in cold 
AIHA. 
In M. suis infections autoreactive antibodies are of central importance for the 
pathogenesis, i.e. in producing anaemia [11, 12]. Beyond cold reactive antibodies of 
the isotype IgM targeting so far unidentified erythrocyte carbohydrates, warm 
autoreactive antibodies of the isotype IgG upregulated during the acute phase of an 
experimentally induced M. suis infection have been described by our group [13]. 
However, detailed characteristics of potential antigens targeted by these autoreactive 
IgGs remained undescribed. Two dimensional immunoblot analysis revealed only 
one porcine protein, i.e. actin being potentially recognised by these antibodies [13, 
14]. Actin is known to play a role in autoimmune hepatitis type 1 (AIH-1) where F-
actin reacting antibodies are characteristic [19]. To our knowledge, this is the first 
report and evidence for autoreactive antibodies directed against actin in warm AIHA.  
In particular, characterising these autoantigenic structures and its mechanisms is an 
essential basis for understanding the pathogenesis of warm AIHA when associated 
with M. suis infections, and in general. Typically, induction of autoreactive antibody 
production is caused by a misguided upregulation of naturally occurring B-cells 
specific for self antigens, the occurrence of altered self antigens, the appearance of 
previously cryptic antigens, and a loss of tolerance to self antigens due to molecular 
mimicry.  
In healthy humans as well as in animals antibodies recognizing cytoskeletal 
components as actin, spectrin or band 3 are necessary to maintain tissue 
homeostasis [20]. Therefore, B-cell clones specific for actin are continually patrolling. 
A misregulation due to M. suis infection could lead to excessive thymus independent 
proliferation of these B-cell clones [12]. Other Mycoplasma species, i.e. 
M. pneumoniae, have been demonstrated to be a polyclonal B-cell activator of mouse 
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splenocytes [21]. Further, Zachary and Smith have described such misdirected 
immune responses to occur in M. suis infections [12]. Whether an uncontrolled 
proliferation of B-cells is the reason for autoreactive IgG molecules targeting actin is 
a topic of future studies. Actually, actin targeting IgG antibodies are upregulated 
during the first clinical attack when M. suis is present in high numbers. This renders 
evidence for the hypothesis of a direct mitogenic stimulus derived from M. suis 
leading to unspecific B cell stimulation. 
A further explanation for the development of autoreactive antibodies is that due to 
damage of red blood cells hidden cytoskeletal proteins become accessible to 
circulating antibodies, be interpreted as non-self and elicit an immune response. It 
has been hypothesised that autoimmune epitopes on red blood cells may be a result 
of contacts with proteolytic enzymes [22]. Electron microscopic studies revealed a 
close association of M. suis cells with the erythrocyte as well as the occurrence of 
striking membrane deformations on the host cell [23, 24]. Considering loads of up to 
4000 M. suis cells per erythrocyte it is quite evident that the cytoskeleton is modified 
by attachment and invasion. Whether active actin remodelling is taking place is topic 
of current investigation in our laboratory.  
The last explanation for the induction of autoreactive antibodies directed against 
host’s actin in M. suis infections is a phenomenon called molecular mimicry. In this 
process, a peptide derived from a pathogen and presented by MHC II must be 
capable of activating a self reactive helper Tcell and, therefore, stimulating specific 
antibody producing B-cells.  
Remarkably, in sera obtained from pigs that were immunised with MSG1 auto-actin-
antibodies already were detectable after immunisation but prior to splenectomy and 
challenge with M. suis. These findings strongly support the hypothesis that MSG1 is 
involved in inducing autoimmunity by molecular mimicry. Evidence for cross-reactivity 
between MSG1 and actin was gained in a heterologous system. To test whether actin 
and M. suis actually share potential cross reactive epitopes, the NetMHCpan 
algorithm [25] was used revealing a positive result. The porcine SLA-2*0201 (swine 
lymphocyte antigen) would strongly bind and therefore present the peptide 
LTLKYPIEH derived from porcine actin as well as RTLKYYISL derived from MSG1 to 
the same circulating T-cells. The identity between these peptides was calculated to 
be 55 % which is enough for cross-reactivity. Degeneracy in both the TCR and MHC 
peptide-binding motifs reduces the sequence-specific requirement to only a few 
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crucial residues [26-28]. It remains to be elucidated by systematic in vitro stimulation 
assays whether these peptides actually play a role in pathogenesis of AIHA due to 
M. suis infection.  
In RBCs as in many other cell types β-actin is present. Only in muscle cells α-actin is 
predominant. If the identified strongly β-actin binding antibodies would encounter 
their target ubiquitously, not only RBCs would be affected. There is evidence that 
lymphocytes and epithelial cells are harmed during M. suis infection (own 
unpublished observations). Cytoskeletal proteins in cells with intact plasma 
membranes are cryptic for antibodies. However, if the cell got harmed by M. suis 
interaction, β-actin would become accessible. Notably, clinical signs expected by 
autoreactive processes targeting the muscular actin form (α-actin) have not yet been 
observed.  
In autoimmune diseases including AIHA misdirected IgG1 and IgG3 antibodies play 
an important role due to efficient binding to FcReceptorIII (FcRIII) molecules on 
macrophages [16, 29]. Interestingly, the antibodies that predominantly recognised 
actin were rather of the subtype IgG2. Immune complexes with this subtype activate 
the alternative pathway of complement cascade and are important in defence against 
encapsulated bacteria [30, 31]. However, the consequences of autoreactive IgG2 
upregulation during M. suis infection remain unclear. Unfortunately, no statement 
about the presence of IgG3 antibodies and their role in M. suis infection can be given 
since secondary antibodies for this porcine subtype were not available. 
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Conclusions 
Overall, we record that autoreactive IgG antibodies upregulated during the infectious 
anaemia of the pig induced by M. suis recognise actin. These autoreactive antibodies 
obviously are involved in the pathogenesis of the severe anaemia observed during 
the infection. Interplay of several mechanisms, i.e. a blastogenic response due to 
unspecific lymphocyte proliferation, direct damage of red blood cells and molecular 
mimicry are assumed to take place. To our knowledge, this is the first report of 
autoreactive actin antibodies in context with AIHA. Human idiopathic haemolytic 
anaemias do not show a very high incidence but patients suffer from severe 
symptoms. Haemotrophic mycoplasmas have not been cultivated in vitro and, 
therefore, are not detected in routine diagnostics. What if these unknown bacteria 
were to play a role? Infections with haemotrophic mycoplasmas of immune 
compromised human beings have been reported [9, 10]. As Sokol and co-workers 
stated in a review of 1985, pathogenesis of AIHA is very complex. They 
recommended that one retained an open mind and did not become too fervent a 
supporter of any particular theory [32]. In our opinion, the experimentally M. suis 
infected splenectomised pig represents a useful model for investigations in AIHA due 
to controllable inducible symptoms. 
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Methods 
Preparation of screening antigens 
To screen for autoreactive antibodies blood from healthy pigs was prepared 
accordingly to M. suis antigen preparations as described in previous publications [33, 
34] with slight modifications. Briefly, blood cells from M. suis negative pigs were 
sedimented by centrifugation at 300xg for 15 min at room temperature (RT). Plasma 
and buffy coat were discarded. The erythrocytes were suspended in phosphate-
buffered saline (1xPBS; Biochrom Ag, Berlin, Germany) containing 0.15 % Tween20 
and 3 % EDTA, and incubated 20 min at RT with shaking. Debris and erythrocytes 
were removed by low-speed centrifugation (500xg, 20 min, RT). Supernatant was 
centrifuged at 25000xg for 120 min at 4 °C. The resulting pellet was resuspended in 
sterile 1xPBS at a concentration of 1 mg/ml. The preparation was IgG and albumin 
depleted using ProteoExtract® Albumin/IgG Removal Kit, Maxi (Calbiochem, Merck, 
Geneva, Switzerland) according to the manufacturer’s recommendations and stored 
in 100 µl aliquots at -80 °C until further use. The preparations were referred to as 
negative Antigen (neg Ag). 
Sera reactive with neg Ag were further tested with IgG depleted erythrocyte lysate 
(ECL), and with several actin preparations. ECL was prepared by hypotonic lysis of 
erythrocytes obtained from a healthy pig. Red blood cells were washed three times 
with 1xPBS (500xg, 15 min, RT) and resuspended in ice cold lysis buffer 
(5 mM Na2PO4, 1 mM  EDTA, pH 7.6, Sigma) in a ratio of 1:1 (v/v). After incubation 
on ice for 5 min ghosts (remainings of lysed cells) were pelleted (30000xg, 15 min, 
4 °C). This procedure was repeated until the pellet turned white. The white pellet was 
washed in 1xPBS, homogenised by ultrasonication on ice and IgG depleted. 
Concentration was set to 1 mg/ml with 1xPBS and stored in 1 ml aliquots at -80 °C 
until further use.  
Muscular actin (α-actin) of pig and rabbit was obtained from Sigma, Buchs, 
Switzerland. Cytoskeletal actin of the pig (β-actin) was not commercially available 
and therefore produced recombinantly (see 2.3). 
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Screening of sera by ELISA  
Sera were obtained from previous studies using a splenectomized pig model for the 
experimental M. suis infections [15]. Sera were divided into two groups: Group 1 
consisted of sera of animals that were immunised with a recombinant immunogenic 
surface protein of M. suis (MSG1) [15] prior to splenectomy and M. suis infection. 
Sera in group 2 were from splenectomised, M. suis infected pigs without 
immunisation [13]. 
Porcine sera were screened for autoreactivity by ELISA as described previously [35]. 
Briefly, 100 ng of IgG depleted neg Ag were coated to individual wells of microtiter 
plates. Sera obtained from pigs used in previous studies [13, 15] were tested in 
duplicates. Sera were drawn prior to M. suis infection, after immunisation in group 1 
(I), during first clinical attacks (II), between first and second clinical attack (III), and 
during the second clinical attack (IV). Sera reactive with neg Ag were further tested 
for reactivity with ECL, α-actin of pigs as well as of rabbits, and with porcine β-actin. 
Protein concentration was 100 ng / well. OD values (λ = 405 nm) were determined 
and normalised to a negative control (pool of 10 sera from healthy pigs). Cut-off 
values were set at three times the standard deviation of negative controls. 
To determine subtypes of autoreactive antibodies monoclonal antibodies targeting 
porcine IgG1 and IgG2 (Prionics, Schlieren, Switzerland) were used 1:1000 in 
PBS/0.05 % Tween20. Horse-radish-peroxidase labelled antibodies to mouse IgG 
(Sigma) diluted 1:5000 in PBS/0.05 % Tween20 were used for detection.  
Cloning and expression of porcine cytoskeletal actin  
Cytoskeletal actin (β-actin) of the pig was commercially not available. Based on the 
encoding mRNA sequence (Genbank:AY550069), the gene was de novo synthesised 
and optimised for E. coli codon usage by Eurofins (Martinsried, Germany). For 
cloning, specific recognition sites for endonucleases were introduced (XhoI at the 5’ 
end and HindIII at the 3’ end). For expression, the gene ligated into the expression 
vector pBadMycHisA (Invitrogen) using T4 ligase obtained from Roche, Basel, 
Switzerland (overnight, 14 °C). The insert containing vector was transformed into 
E. coli LMG194 (Invitrogen). E. coli transformants were grown at 37 °C, expression of 
the recombinant porcine β-actin was induced by addition of 0.02 % arabinose at 
OD600 = 0.4. After incubation of the cells for additional 4 h at 37 °C, the 6xHis-tagged 
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protein was purified by nickel affinity chromatography (GE Healthcare, Glattbrugg, 
Switzerland) according to the manufacturer’s recommendations. To solve the protein 
from inclusion bodies, 8M Urea was used for purification. The recombinant protein 
was further purified by electro elution out of 10 % polyacrylamide gels using the 
electro-eluter model 422 (Biorad, Reinach, Switzerland). The eluted protein was 
precipitated by adding 3 volumes of ice cold acetone and incubation over night at -
20 °C. The protein was harvested by centrifugation (10000xg, 90 min, 4 °C), allowed 
to dry, resuspended in 1xPBS, and stored in aliquots of 1mg/ml at -80 °C.  
Production of hyperimmune sera  
One milligram of protein (recombinant MSG1 [15], recombinant porcine β-actin as 
well as porcine α-actin (Sigma, Buchs, Switzerland)) was mixed with complete 
Freund’s adjuvant (Sigma) in a ratio of 1:1 (v/v) and injected subcutaneously to 
rabbits. Two boost injections (proteins were mixed 1:1 (v/v) with incomplete Freund’s 
adjuvant) were given two and four weeks later, respectively. Six weeks after the first 
injection rabbits were bled; the serum was harvested and stored in aliquots at -20 °C. 
Immunisations were conducted under the registration number 144/2008 in 
accordance with legal prescriptions. 
Western Blotting  
Cross-reactivity of rabbit hyperimmune sera produced against MSG1 and porcine α-
actin was tested by Western Blot as described previously [13]. Briefly, actin and 
MSG1 were loaded on 10 % polyacrylamide gels containing 1 % SDS (w/v), and 
transferred to a nitrocellulose membrane (Whatman Protran®, GE Healthcare). Free 
binding positions on the membrane were blocked with skim milk (Sigma, 2 % w/v in 
Tris buffered saline; TBS), and probed by rabbit hyperimmune sera (diluted 1:100 in 
TBS containing 2 % skim milk powder) produced against recombinant MSG1 and α-
actin, respectively. A secondary antibody reactive with pig IgG (Sigma) and coupled 
to horse radish peroxidase (HRP) diluted 1:5000 in TBS containing 2 % (w/v) skim 
milk powder was used. The substrate for the HRP was H2O2 (Sigma); 4-Chloro-1-
naphtol (Sigma) was used as chromogenic agent. The reaction was stopped by 
adding MQ water (Millipore, Zug, Switzerland). 
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Search for cross-reactive epitopes  
To identify potential cross-reactive epitopes an epitope finder program referred to as 
NetMHCpan algorithm was used [25]. Published protein sequences of MSG1 
(UniProtKB/TrEMBL:Q05G10), porcine α-actin (Swiss-Prot:P68137.1) and porcine β-
actin (Swiss-Prot:Q6QAQ1.2) were used as input.  
Statistical analysis  
Resulting ELISA OD values measured at wavelength λ = 405 nm were compared to 
each other by linear regression models using the SigmaPlot software, Version 10.0 
(SPSS Inc., Chicago, IL, U.S.A). To show independency of values between two 
groups the unpaired student t-test was applied (significant difference if P ≤ 0.05). 
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
Serum reactivities with neg Ag at several time points (I to IV). A: Group 1 
comprises animals that were immunised with MSG1 prior to infection with M. suis and 
splenectomy. Pigs in group 2 were splenectomised and infected with M. suis. B: 
Occurrence of autoreactive antibodies during the time course of infection, 
representative for one animal of each group. 
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Figure 2 
Actin as autoantigen and species specificity. Linear regressions between 
reactivities with neg Ag and ECL (A) as well as with neg Ag and α-actin (B) are 
shown for 16 sera. Additionally, 95 % confidence and 95 % prediction bands are 
shown. C: comparison between reactivities with α-actin of rabbits and pigs. 
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8.2 Programmed cell death of red blood cells influences development of 
anaemia in pigs infected with Mycoplasma suis 
 
Kathrin M. Felder, Katharina Hoelzle, Katrin Gröbel, and Ludwig E. Hoelzle 
 
Manuscript in preparation 
A reason for shortened life-span of M. suis infected red blood cells is eryptosis. The 
incidence of eryptosis was measured over the infection course of experimental 
infectious anaemia of pigs and compared to haematological parameters, bacterial 
load and disease severity. 
I collected samples, did the study design, analysed samples for haematological 
parameters and eryptosis occurrence and wrote the manuscript. 
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Programmed Cell Death of Red Blood Cells Influences 
Development of Anaemia in Pigs Infected with 
Mycoplasma suis 
 
Kathrin M. Felder, Katharina Hoelzle, Katrin Groebel, Ludwig E. Hoelzle* 
Instiute for Veterinary Bacteriology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland 
 
Abstract 
Severe anaemia is a main clinical sign of pigs infected with M. suis. So far, 
pathogenesis has not been clarified. The involvement of autoreactive mechanisms 
and direct cell lysis due to M. suis was described. Based on literature findings the 
idea occurred that M. suis infection triggered programmed cell death and therefore 
aggravated anaemia. In erythrocytes, suicidal cell death is referred to as eryptosis 
and is among other signs characterised by cell shrinkage, microvesiculation and 
phosphatidyl-serine (PS) exposure on the outer membrane leaflet. In this study, we 
evaluated the eryptosis occurrence over the time course of infection with M. suis and 
related it with development of anaemia. For this, three M. suis strains differing in 
virulence were used. All three strains were able to induce eryptosis. In pigs infected 
with the highly virulent strain, anaemia correlated at the beginning with upregulation 
of eryptosis. The moderately virulent strain seems to be controlled at the beginning 
by removal of infected cells from the circulation system. Therefore, the progress of 
anaemia decelerated. Infections with the low virulent strain are controlled by means 
of eryptosis and anaemia did not occur. Additionally, serum and plasma of an acutely 
ill pig was shown to induce PS exposure on erythrocytes drawn from healthy pigs.  
 
*Corresponding author: PD Dr. L. E. Hoelzle, Institute for Veterinary Bacteriology, 
Winterthurerstr. 270, 8057 Zürich. Phone: +41446358613, Fax:+416358912. 
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INTRODUCTION 
The main cause of anaemia in pigs is the infection with Mycoplasma suis. The 
disesase is referred to as infectious anaemia of pigs (IAP). M. suis belongs to the 
group of haemotrophic mycoplasmas that are closely associated with red blood cells 
of several animals [1, 2]. Clinical signs that are accompanied by high bacterial loads 
(up to 1012 bacteria per ml of blood) are raise of body temperature, hypoglycaemia 
and severe anaemia. Pigs show laboured breathing due to insufficient oxygen 
transport and sometimes die of hypoglycaemic shock if untreated. Tetracycline saves 
pigs from death but M. suis is not completely eradicated from its host. The following 
weeks are characterised by milder anaemia, higher susceptibility to other infections 
and occurrence of acrocyanosis due to cold agglutinins [3, 4]. The chronic phase is 
interrupted by M. suis growth peaks and the aforementioned clinical signs. These 
“clinical attacks” get milder at each time and pigs survive without antibiotic therapy 
from the third attack on [1].  
During blood circulation, the integrity of erythrocytes is constantly challenged [5]. 
They are exposed to oxidative stress in the lung, osmotic changes when travelling 
through kidney medulla and are squeezed by passing small capillaries. As response, 
red blood cells can undergo suicidal cell death [6, 7]. This process is referred to as 
eryptosis and is characterised by cell shrinkage, membrane blebbing, activation of 
proteases and phosphatidylserine exposure at the outer membrane leaflet [8]. In 
vitro, eryptosis is inhibited by cystein protease inhibitors as Ac-DEVD-CHO or Leuptin 
[6]. Nevertheless, eryptosis is independent of caspases. Red blood cells indeed were 
described to contain pro-caspase-3 and pro-caspase-8, but the enzymes are not 
activated. In erythrocytes, inhibitors of cystein proteases rather target µ-calpain than 
caspases which indicates that µ-calpain is involved in triggering eryptosis [9]. 
The anaemia observed in context with M. suis infection is caused by at least three 
mechanisms: (I) direct interaction between M. suis and the red blood cell, (II) 
autoreactive mechanisms and (III) eryptosis [10, 11]. The interaction between the 
bacterium and its host cell is intimate. The bacteria live and divide on and in 
erythrocytes [12]. The close contact leads to membrane destruction and structural 
changes which are signals for macrophage uptake and programmed cell death. The 
aim of this study was to evaluate eryptosis occurrence in M. suis infected pigs and to 
analyse its impact on development of anaemia, one of the main clinical signs in IAP.  
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METHODS 
Pigs 
Weaned piglets (female, “deutsche Landrasse”) were housed in a pen of 20 square 
meters in groups of four animals. After one week, pigs were splenectomised and 
allowed to recover. At the age of 7 weeks they were infected by injecting 1 ml of 
M. suis containing blood (106 to 107 bacterial cells per ml) i.m. Beginning at the day 
of infection body temperature was recorded daily and pigs were bled for sampling 
twice a week. Animal experiments were conducted under the registration number 
55/2007 with legal prescriptions. 
 
M. suis strains 
Three different M. suis strains were used for the experiments. They were classified 
according to their virulence, i.e. low, moderate and high. The low virulent strain is 
referred to as 146/5 (GenBank:FN391021), is not invasive and the pigs survive if 
treated with tetracycline. In experimental infections first clinical signs appear between 
14 dpi and several weeks dpi. The moderate strain, referred to as 3804 is not 
invasive but difficult to be controlled with antibiotics. First clinical signs are observed 
from 10 dpi and pigs survive for several days. The highly virulent strain 
(GenBank:FN391022) is referred to as KI, invasive and untreatable by means of 
tetracycline. An infected pig dies within 8 dpi. These animals were exsanguinated on 
the day of first appearance of high fever. The 16S gene sequence is identical in all 
three M. suis strains.  
 
Quantification of M. suis 
Quantification of M. suis was performed as described previously [13]. Briefly, DNA 
was extracted from 200 µl EDTA-anticoagulated blood by the blood and tissue kit 
(Sigma, Buchs, Switzerland) according to the manufacturer’s recommendations and 
analysed by a quantitative PCR targeting the g1 adhesin gene of M. suis. In parallel, 
a standard curve was measured to calculate M. suis genome equivalents. 
 
Haematological parameters 
White blood cell count including differential blood cell analysis, red blood cell count, 
haemoglobin concentration and haematocrit values were determined using a 3-DIFF 
Analyzer (ABX Micros CRP, AxonLab, Baden, Switzerland) according to the 
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manufacturer’s recommendations. EDTA anticoagulated blood was tested within one 
hour of blood withdrawal.  
 
Quantification of eryptosis 
To determine the rate of eryptotic cells the red blood cells were purified from EDTA 
blood by three washing steps with 1xPBS (400 x g, 5 min, 20 °C). 107 cells were 
stained with PKH-26 (Sigma), a membrane cell linker dye to stain cells with intact cell 
membranes. To detect cells showing phosphatidyl-serine exposure, the erythrocytes 
were counterstained with 100 µl AnnexinV-Fluos working solution (Roche) for 15 min. 
The reaction was stopped by addition of 500 µl HEPES Buffer (10 mM HEPES, 
pH 7.4, 140 mM NaCl, 5 mM CaCl2). Cells were immediately analysed by flow 
cytometry (FACScalibur, BD Biosciences, Switzerland). 10000 red blood cells were 
recorded; double stained cells were considered as to be eryptotic and quantified. To 
perform instrument settings, cells fixed with 4 % Paraformaldehyde (PFA) were used. 
These cells stain all positive with AnnexinV, a phaenomenon described to occur as 
well in platelets fixed by means of PFA [14]. 
In vitro induction of eryptosis 
Cells were stained with PKH-26 as described above. 106 stained cells were 
incubated over night at 37 °C with 100 µl of serum or plasma of a M. suis infected 
pig. As controls, serum and plasma obtained from the same pigs before infection with 
M. suis were used. As positive control, cells were incubated with 2.5 mM CaCl2 and 
0.5 µM Ionomycin (Sigma) in 1xPBS.  
 
Microscopy 
Scanning electron microscopy (SEM) was performed as described previously [12]. 
Briefly, cells were fixed by means of 1 % Glutaraldehyde immediately after blood 
withdrawal and stored at 4 °C until use. Cells were settled on carbon coated 
coverslips, dehydrated by increasing concentrations of acetone and dried. The cells 
were sputter coated with 20 nm platinum and analysed with a Zeiss Supra 50 VP 
scanning electron microscope. 
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Statistical analysis 
To test whether two groups differed significantly in eryptosis development; the P-
values were calculated with the unpaired student t-test. Two groups were considered 
as significantly different if P ≤ 0.05.  
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RESULTS 
Instrument settings 
One characteristic of eryptotic cells is the breakdown of membrane asymmetry. 
Specific staining with AnnexinV-Fluos allows the quantification of these cells by 
FACS. Cells undergoing suicidal cell death differ from necrotic cells by maintaining 
the plasma membrane integrity. Therefore, a membrane dye staining only cells with 
intact cell membranes (PKH-26) was used as additional marker. To perform 
instrument settings on the FACS Calibur eryptosis was induced by incubation with 
2.5 mM CaCl2 and 0.5 µM Ionomycin. As controls, cells drawn from healthy pigs were 
stained.  
 
Visualisation of eryptotic cells 
Samples from M. suis infected pigs containing eryptotic red blood cells (as seen by a 
significant higher amount of double stained cells compared to blood of healthy pigs) 
were analysed by scanning electron microscopy. The characteristic changes as cell 
shrinkage, change in shape from discocytic to sphaerocytic and microvesiculation 
were observed (Figure 1A). For quantification, cells were double stained with 
AnnexinV and PKH-26 and analysed on by flow cytometry. 10000 erythrocytes were 
taken into consideration (Figure 1B). The amount of double stained cells was 
recorded (Figure 1C). In all M. suis infected animals eryptosis was observed.  
 
Quantification of eryptosis over the time course of an M. suis infection 
To evaluate the impact of eryptosis for development of anaemia, pigs were infected 
with three different strains of M. suis, i.e. highly virulent (hv), moderately virulent (mv) 
and low virulent (lv) and bled twice a week. Haematological parameters were 
recorded and eryptosis occurrence was tested. Table 1 gives an overview of the 
haematocrit, bacteraemia and double stained red blood cells of the analysed pigs. In 
pigs infected with the hv M. suis strain the disease progressed extremely fast and 
symptoms were fatal. In these animals a correlation between severity of anaemia as 
well as of bacterial load with occurrence of doubled stained cells was observed 
(Table 1, Figure 2). Short before euthanasia, red blood cells were no more stained 
with PKH-26. At these time points, the membrane damages were too severe and 
intravascular lysis occurred. Therefore, the values of eryptotic cells were minimised 
and no cells were double stained. In blood samples of the pig infected with the mv 
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M. suis strain eryptosis activity was measurable at day 7 post infectionem. 
Afterwards, no eryptosis was observed. In parallel, the bacterial load increased and 
the haematocrit decreased. The animal was treated with tetracycline. At day 16 p.i. 
the bacterial load was decreased but the anaemia was very severe. The animal had 
to be euthanised due to poor general state of health. For the animal infected with the 
lv strain eryptotic activity was measured after three weeks of infection. The bacterial 
load correlated directly to the percentage of double stained red blood cells. During 
this time the animal did not show any clinical signs.  
 
In vitro induction of eryptosis 
To prove the presence of suicidal cell death mechanisms, red blood cells taken from 
healthy pigs (n = 3, I to III) were incubated with plasma and serum from acutely ill 
pigs. The M. suis loads of serum and plasma were determined to be 9.74 x 108 per 
ml and 6.08 x 1011 per ml, respectively. A significant upregulation of double stained 
erythrocytes was observed (Table 2). Figure 3 illustrates the amount of double 
stained cells. The difference between serum and plasma incubations and control 
incubations was significant (P ≤ 0.05). Freshly drawn red blood cell did not stain with 
AnnexinV. In Figure 4 density plots of replica I to III are shown. 
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DISCUSSION 
Interestingly, effector caspases are required for red blood cell formation in 
erythropoiesis [15]. Daugas et al proposed that the differentiation and enucleation of 
the red blood cell during development was a sort of abortive apoptosis [9]. He 
therefore considered the mature erythrocyte as an organelle free mummy created by 
caspase activation. Until then, researchers believed that mature red blood cells were 
not able for programmed cell death due to lack of nucleus and mitochondria. It was in 
2001 when two independent research groups proved the opposite [6, 7]. Upon stress 
erythrocytes undergo conformational changes as cell shrinkage, vesiculation and 
exposure of phosphatidylserine on the outer leaflet of the plasma membrane, all well 
known features occurring during apoptosis of nucleated cells. The exact mechanisms 
of eryptosis were then clarified by the group of Lang [5].  
Several stimuli and diseases trigger eryptosis [16]. Among these are energy 
depletion, oxidative stress, osmotic shock, cyclosporine, peptidoglycans, 
prostaglandin E2, sepsis, malaria and glucose-6-dehydrogenase-deficiency [17-22]. 
Upon invasion of red blood cells Plasmodium falciparum induces formation of ion 
channels over the erythrocyte membrane for uptake of nutrients, Na+ and Ca2+ ions 
and disposal of waste products [17, 23]. This channel formation leads to upregulation 
of eryptosis, removal of infected cells and therefore removal of bacteria from the 
body. Suicide therefore represents a defence mechanism against malaria [24]. 
M. suis as well is able for cell invasion [12]. In this study, an increase in red blood 
cells exhibiting phosphatidylserine on their surface was observed during 
bacteraemia. 
In our study we observed eryptosis as well in pigs infected with the non-invasive 
M. suis strain. Eryptosis in animals infected with this strain therefore seems to be 
induced by some soluble substances produced by the bacterium. In these pigs 
anaemia was controlled by eryptosis, not induced. Additional studies are necessary 
to find such eryptosis-triggering factors of non-invasive M. suis cells. 
A main clinical sign of acute IAP is severe anaemia caused by several mechanisms. 
We observed upregulation of autoreactive antibodies targeting actin during disease 
states with high M. suis loads [11]. These antibodies can bind actin only if the cell is 
damaged and its actin gets accessible. The close association of M. suis cells with the 
erythrocyte leads to so far unknown changes in the cytoskeleton and the cell 
membrane. A possible explanation would be that channel formation by the invader 
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could induce such changes. Therefore, a combination of increased accessibility of 
actin and eryptosis rate is likely to account for diminution of erythrocytes and 
therefore severe anaemia.  
The detected patterns of eryptosis occurrence differed in pigs infected with different 
M. suis strains. In infections with a highly virulent strain, the eryptosis process is 
upregulated but fails to control the infection. Erythrocytes are lysed intravascularly by 
some other mechanism as autoreactive antibodies targeting the actin or direct lysis 
by M. suis [11]. In the pig infected with the moderate M. suis strain eryptosis was 
observed at the beginning (7 dpi). In blood samples taken later no significant amount 
of double stained cells was observed. However, the serum taken at day 14 pi, when 
acute clinical signs were observed, was able to induce eryptosis in erythrocytes from 
healthy, M. suis negative pigs. The pig infected with the low virulent M. suis strain 
never showed clinical signs. Eryptosis occurrence was stated from day 21 to day 35 
pi. During this time a measurable load of M. suis cells was detected in the blood. 
Here, eryptosis was successful in defence against the infection. The haematocrit 
slightly decreased. Pigs in this study used eryptosis as the first line of defence 
against M. suis cells invading red blood cells. Later, when M. suis was able to growth 
the mechanism failed and infection got fatal. Therefore we state, that early anaemia 
is due to sacrifice of infected red blood cells in favour of the individual. Potential 
removal of red blood cells by phagocytosis in early anaemia was already discussed 
in 1985 by Zachary and Smith but no experimental proof was given [3]. In this study 
we confirm the influence of programmed cell death and therefore phagocytosis. Later 
in the experimental infection, severity of anaemia directly correlated with M. suis load. 
Other mechanisms i.e. a combination of direct lysis and misled immune response 
against host actin took over. 
Eryptosis was inducible in erythrocytes from healthy animals by overnight incubation 
with serum and plasma samples taken from acutely ill pigs. Therefore, the 
Mycoplasma cells or a stress signal present in the serum and plasma, respectively, is 
responsible for induction of the death machinery. Noteworthy, a higher rate of 
eryptosis occurrence in human sepsis patients was reported [19]. Authors described 
that erythrocytes of healthy volunteers incubated with plasma from sepsis patients 
triggered phosphatidylserine exposure and therefore eryptosis. The effect was 
attributed to accumulation of sphingomyelinase-induced intraerythrocytic ceramide 
[25]. The reason for sepsis in these patients was diverse. In 8 patients a bacterial 
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causative agent was identified, in one case it was M. pneumoniae. However, the 
plasma samples used were not treated to remove bacteria. 
In context with M. suis infections it is not clear what kind of signal is used for 
triggering suicidal red blood cell death. In both samples, M. suis cells were present. 
Further experiments have to be performed with M. suis free serum and plasma 
samples. A problem is the sterilisation of plasma and serum samples. Filtration is not 
the method of choice out of two reasons. First, mycoplasmas pass filters with 0.2 µm 
pore size, and second, serum and plasma samples are highly viscous. Therefore, it is 
impossible to use filters with smaller pore sizes. Generally, sera are inactivated by 
means of addition of 0.05 % of sodium azide (NaN3). However, no significant 
differentiation considering double staining of red blood cells was observed compared 
to the controls if sera and plasma samples were treated by means of NaN3 (data not 
shown). With this inactivation method bacteria are killed but not removed from the 
samples. Therefore, eryptosis triggering factors still could be present and be active. A 
further possibility is heat inactivation. Here, the unintentional deactivation of potential 
eryptosis triggering factors has to be taken into account. 
Normally, senescent red blood cells are recognised by macrophages and removed 
from circulation in the spleen. Our infection model is the splenectomised pig. 
Theoretically, an accumulation of senescent cells due to the lack of the spleen is 
thinkable. Therefore, we included a splenectomised, non infected pig in our study 
and additionally analysed several samples from splenectomised pigs prior to infection 
with M. suis. There was no increase in red blood cells exhibiting phosphatidylserine 
on their surface compared to healthy, non splenectomised pigs.  
In this study we observed the occurrence of eryptosis in response to infection with 
M. suis. Independent on the virulence of the M. suis strains used eryptosis was 
observed. However, the amount of eryptotic cells and the time-point of occurrence 
differed in animals infected with different strains. Due to correlation of severity of 
anemia with the occurrence of eryptotic cells in mv and hv strains we state that the 
early anaemia is due to suicidal destruction of red blood cells. Later on, other 
mechanisms as autoreactive antibodies and direct lysis due to cell membrane 
damage take over. In pigs infected with the lv M. suis strain eryptosis occurred, but 
anaemia was not observed. Here, eryptosis seems to be an effective defence 
mechanism against M. suis infection. Eryptosis was inducible in healthy erythrocytes 
by incubation with serum and plasma of an infected animal. It remains to be 
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elucidated whether the bacteria directly or some soluble substances present in the 
plasma are the triggering factor for upregulation of eryptosis in M. suis infected pigs. 
 
ACKNOWLEDGMENTS 
The study was supported by the Forschungskredit of the University of Zurich, Zurich.  
  
Ph.D. Thesis, Kathrin Felder 
 
72 
 
REFERENCES 
1. LE Hoelzle: Haemotrophic mycoplasmas: recent advances in 
Mycoplasma suis. Vet Microbiol 2008, 130:215-26. 
2. JB Messick: Hemotrophic mycoplasmas (hemoplasmas): a review and 
new insights into pathogenic potential. Vet Clin Pathol 2004, 33:2-13. 
3. JF Zachary, AR Smith: Experimental porcine eperythrozoonosis: 
T-lymphocyte suppression and misdirected immune responses. Am J Vet 
Res 1985, 46:821-30. 
4. P Schmidt, B Kaspers, A Jungling, K Heinritzi, U Losch: Isolation of cold 
agglutinins in Eperythrozoon suis-infected pigs. Vet Immunol 
Immunopathol 1992, 31:195-201. 
5. KS Lang, PA Lang, C Bauer, C Duranton, T Wieder, SM Huber, F Lang: 
Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005, 
15:195-202. 
6. D Bratosin, J Estaquier, F Petit, D Arnoult, B Quatannens, JP Tissier, C 
Slomianny, C Sartiaux, C Alonso, JJ Huart, et al: Programmed cell death in 
mature erythrocytes: a model for investigating death effector pathways 
operating in the absence of mitochondria. Cell Death Differ 2001, 8:1143-
56. 
7. CP Berg, IH Engels, A Rothbart, K Lauber, A Renz, SF Schlosser, K Schulze-
Osthoff, S Wesselborg: Human mature red blood cells express caspase-3 
and caspase-8, but are devoid of mitochondrial regulators of apoptosis. 
Cell Death Differ 2001, 8:1197-206. 
8. F Lang, KS Lang, PA Lang, SM Huber, T Wieder: Mechanisms and 
significance of eryptosis. Antioxid Redox Signal 2006, 8:1183-92. 
9. E Daugas, C Cande, G Kroemer: Erythrocytes: death of a mummy. Cell 
Death Differ 2001, 8:1131-3. 
10. LE Hoelzle, K Hoelzle, M Helbling, H Aupperle, HA Schoon, M Ritzmann, K 
Heinritzi, KM Felder, MM Wittenbrink: MSG1, a surface-localised protein of 
Mycoplasma suis is involved in the adhesion to erythrocytes. Microbes 
Infect 2007, 9:466-74. 
11. KM Felder, Hoelzle, K., Heinritzi, K., Ritzmann, M., Hoelzle, L.E.: Antibodies 
to actin in pigs suffering from autoimmune haemolytic anaemia. BMC Vet 
Res 2010, submitted. 
Ph.D. Thesis, Kathrin Felder 
 
73 
 
12. K Groebel, K Hoelzle, MM Wittenbrink, U Ziegler, LE Hoelzle: Mycoplasma 
suis invades porcine erythrocytes. Infect Immun 2009, 77:576-84. 
13. LE Hoelzle, M Helbling, K Hoelzle, M Ritzmann, K Heinritzi, MM Wittenbrink: 
First LightCycler real-time PCR assay for the quantitative detection of 
Mycoplasma suis in clinical samples. J Microbiol Methods 2007, 70:346-54. 
14. K Wong, X Li, Y Ma: Paraformaldehyde induces elevation of intracellular 
calcium and phosphatidylserine externalization in platelets. Thromb Res 
2006, 117:537-42. 
15. Y Zermati, C Garrido, S Amsellem, S Fishelson, D Bouscary, F Valensi, B 
Varet, E Solary, O Hermine: Caspase activation is required for terminal 
erythroid differentiation. J Exp Med 2001, 193:247-54. 
16. F Lang, E Gulbins, H Lerche, SM Huber, DS Kempe, M Foller: Eryptosis, a 
window to systemic disease. Cell Physiol Biochem 2008, 22:373-80. 
17. VB Brand, CD Sandu, C Duranton, V Tanneur, KS Lang, SM Huber, F Lang: 
Dependence of Plasmodium falciparum in vitro growth on the cation 
permeability of the human host erythrocyte. Cell Physiol Biochem 2003, 
13:347-56. 
18. M Foller, R Biswas, H Mahmud, A Akel, E Shumilina, T Wieder, F Goetz, F 
Lang: Effect of peptidoglycans on erythrocyte survival. Int J Med Microbiol 
2009, 299:75-85. 
19. DS Kempe, A Akel, PA Lang, T Hermle, R Biswas, J Muresanu, B Friedrich, P 
Dreischer, C Wolz, U Schumacher, et al: Suicidal erythrocyte death in 
sepsis. J Mol Med 2007, 85:273-81. 
20. KS Lang, C Duranton, H Poehlmann, S Myssina, C Bauer, F Lang, T Wieder, 
SM Huber: Cation channels trigger apoptotic death of erythrocytes. Cell 
Death Differ 2003, 10:249-56. 
21. KS Lang, B Roll, S Myssina, M Schittenhelm, HG Scheel-Walter, L Kanz, J 
Fritz, F Lang, SM Huber, T Wieder: Enhanced erythrocyte apoptosis in 
sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase 
deficiency. Cell Physiol Biochem 2002, 12:365-72. 
22. PA Lang, DS Kempe, S Myssina, V Tanneur, C Birka, S Laufer, F Lang, T 
Wieder, SM Huber: PGE(2) in the regulation of programmed erythrocyte 
death. Cell Death Differ 2005, 12:415-28. 
Ph.D. Thesis, Kathrin Felder 
 
74 
 
23. K Kirk: Membrane transport in the malaria-infected erythrocyte. Physiol 
Rev 2001, 81:495-537. 
24. M Foller, D Bobbala, S Koka, SM Huber, E Gulbins, F Lang: Suicide for 
survival-death of infected erythrocytes as a host mechanism to survive 
malaria. Cell Physiol Biochem 2009, 24:133-40. 
25. KS Lang, S Myssina, V Brand, C Sandu, PA Lang, S Berchtold, SM Huber, F 
Lang, T Wieder: Involvement of ceramide in hyperosmotic shock-induced 
death of erythrocytes. Cell Death Differ 2004, 11:231-43. 
  
Ph.D. Thesis, Kathrin Felder 
 
75 
 
FIGURES AND TABLES 
 
Figure 1 Quantification of eryptotic cells infected with the highly virulent M. suis 
strain. A: Scanning electron micrographs of a discoid, normal red blood cell and a 
sphaeric eryptotic cell showing microvesiculation are shown. B: Density plots of the 
erythrocyte population. 10000 cells in gate R1 were considered for quantifications. 
C: Density plots showing the relative fluorescence intensities of cells in gate R1. The 
eryptotic and therefore double stained cells are found in the upper right quadrant. 
Numbers indicate percentage of double stained cells in gate R1.   
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Figure 2 Correlation of doubled stained red blood cells with haematocrits. 
A: Infection with the highly virulent strain. The severity of anaemia negatively 
correlates with the amount of double stained red blood cells. At day 10 p.i. the cells 
did no more stain with PKH-26 due to severe damage and intravascular lysis. 
B: Infection with the moderately virulent M. suis strain. At the beginning of the 
infection course eryptosis is upregulated. Later, anaemia progresses without 
appreciable eryptotic activity. C: Infection with the low virulent M. suis strain. 
Eryptosis is observed from day 21 post infection. Haematocrit levels are constant. 
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Figure 3 Incubations of red blood cells with serum and plasma from acutely ill and 
healthy pigs. Bars show means of percentage of double stained red blood cells. 
Additionally, the error bars are shown. Fresh: cells were stained immediately after 
blood withdrawal. Serum and Plasma A: cells were incubated over night with serum 
and plasma samples obtained from an acutely ill pig. Serum and Plasma C: As 
controls, cells were incubated with samples obtained from the same pig but prior to 
M. suis infection. The differences between A and C were significant as indicated by 
P-values < 0.05 (Table 2). 
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Figure 4 Density plots of double stained red blood cells that were stained with 
AnnexinV and PKH-26 immediately after withdrawal or after incubation with serum or 
plasma from an acutely ill pig. Cells appearing in the upper right quadrant of each 
panel were considered as eryptotic due to double staining. Numbers indicate 
percentage of 10000 red blood cells. 
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Table 1 
 
Overview of data obtained. Pigs were infected with three different M. suis strains. Eryptosis activity 
was compared to severity of anaemia (haematocrit) and bacterial load.
Animal dpi1 % dsc2  
Bacterial 
load / ml 
blood 
Haematocrit M. suis 
strain 
status 
1828 3 0.29 5.32E+03 36.3 hv3  
1828 8 18.61 1.61E+11 25.5 hv euthanised
1846 3 1.37 2.42E+03 36.2 hv  
1846 8 13.04 2.38E+09 36.1 hv  
1846 9 19.35 2.03E+10 33.2 hv  
1846 10 0.29 3.62E+10 25.4 hv euthanised
5271 2 0.3 4.83E+02 38.2 mv4  
5271 7 4.54 1.10E+03 39.4 mv  
5271 10 0.91 7.66E+05 38.6 mv  
5271 12 1.61 1.40E+11 36.1 mv  
5271 14 1.99 7.22E+11 20.8 mv  
5271 16 1.39 6.10E+07 14.4 mv euthanised
5275 18 0.33 0 38.0 lv5  
5275 21 1.40 0 36.4 lv  
5275 27 3.09 6.25E+03 34.2 lv  
5275 32 1.70 1.06E+03 36.4 lv  
5275 35 1.09 2.60E+01 35.1 lv  
5275 41 0.05 0 33.3 lv survived 
5280 2 0.15 2.47E+05 35.2 hv  
5280 7 6.55 7.65E+03 36.7 hv  
5280 12 15.6 8.42E+08 28.6 hv euthanised
1 days post infectionem, 2 percent of double stained red blood cells, 3 highly virulent, 4 moderately 
virulent, 5 low virulent. 
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Table 2 
 
 
 
 
Double stained red blood cells after incubation with serum or plasma, respectively. 106 
purified red blood cells from healthy pigs were incubated over night with 100 µl of serum or 
plasma from an acutely ill pig (serum A, plasma A). Accordingly, cells were incubated with 
control preparations from the same pig taken prior to M. suis infection (serum C, plasma C). 
P-values indicate significance between experimental and control incubations for each sample 
if ≤ 0.05. Staining properties of cells was evaluated as well before incubation (fresh).  
 I II III 
% dsc P value % dsc P value % dsc P value 
fresh 0.59 ± 0.18  0.30 ± 0.21  0.08 ± 0.04  
serum A 2.11 ± 0.89 
0.0003 
2.11 ± 0.29
0.0085 
2.72 ± 0.68 
0.003 serum C 1.21 ± 0.54 1.50 ± 0.50 2.18 ± 0.15 
plasma A 9.09 ± 1.80 
0.0002 
2.22 ± 0.09
0.0014 
4.13 ± 0.23 
0.0005 plasma C 5.03 ± 1.34 0.75 ± 0.43 3.13 ± 0.23 
I – III Replica, dsc: double stained red blood cells. 
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8.3 MSG1, a surface-localised protein of Mycoplasma suis is involved in the 
adhesion to erythrocytes 
 
Microb Infect. 2007; 9:466-474. 
 
Ludwig E. Hoelzle, Katharina Hoelzle, Marianne Helbling, Heike Aupperle, Heinz A. 
Schoon, Mathias Ritzmann, Karl Heinritzi, Kathrin M. Felder, Max M. Wittenbrink. 
This publication describes the identification and characterization of MSG1 as a M. 
suis protein involved in attachment to the erythrocyte. The protein is analogous to 
GAPDH and is surface-localised in M. suis as well as in E. coli transformants. E. coli 
transformants expressing a fusion protein of MSG1 and GFP were used for functional 
studies concerning the adhesion process to red blood cells.  
I performed the FACS analysis to evaluate adhesion of recombinant MSG1_GFP 
expressing E. coli cells to red blood cells.  
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8.4 Vaccination with the Mycoplasma suis recombinant adhesion protein 
MSG1 elicits a strong immune response but fails to induce protection in pigs 
 
Vaccine. 2009; 27(39):5376-82.  
Katharina Hoelzle, Susanne Doser, Mathias Ritzmann, Karl Heinritzi, Andreas Palzer, 
Sabine Elicker, Manuela Kramer, Kathrin M. Felder, Ludwig E. Hoelzle. 
MSG1 and MSG1 expressing E. coli cells were used to vaccinate pigs prior to 
experimental infection with M. suis. A strong immune response was induced but 
failed to protect the animals from IAP. However, anaemia observed in E.coli_MSG1 
vaccinated pigs was milder than in control animals. 
My contribution was the analysis of splenocyte supernatants of IFN-γ concentration. 
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